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The biosynthetic pathway leading to 2-aminoethylphosphonate in 
Tetrahymena pyriformis was determined. A cell-free homogenate of 
T. 
pyriformis converted phosphoenolpyruvate to AEP in 37 %yie
ld, 
phosphonopyruvate to AEP in a 11 % yield and phophonoacetaldehyde
 to 
AEP in an 83% yield. The Tetrahymena pyriformis enzyme, PEP mutas
e 
was purified. The PEP Mutase catalyzes the rearrangement 
of 
phosphoenolpyruvate to phosphonopyruvate and the equilibrium const
ant 
is >500:1 in favor of phosphoenolpyruvate. To distinguish between 
an 
intra-and intermolecular reaction pathway for this process an equimo
lar 
mixture of [P= 1 ao, C(2)-18O]thiophosphonopyruvate and (all -
16Q)thiophosphonopyruvate was reacted with the PEP mutase and 
the 
resulting products were analyzed by 
31 P-NMR. The absence of the cross-
over product [C(2)-18O]th iophosphonoenolpyruvate in the product mixture 
was interpreted as evidence for an intramolecular reaction pathway. To 
distinguish between a concerted and stepwise intramolecular reaction 
pathway the pure enantiomers of the chiral substrate 
[P= 18Q]thiophosphonopyruvate were prepared and the stereochemical 
course of their conversion to chiral [P= 18O]thiophosphoenolpyruvate was 
determined. Based on the observed conversion of (Sp) -
[P= 1 Bo]thiophosphonopyruvate to (Sp)-[P= 180]thiophosphoenolpyruvate 
and (Rp) - [P = 18Q]thiophosphonopyruvate to (Rp)-
[ P= 1 BQ]thiophosphoenolpyruvate it was concluded that the PEP 
phosphomutase reaction proceeds with retention of the phosphorus 
configuration and therefore by a stepwise mechanism. The similar 
reactivity of the oxo and thio substituted phosphonopyruvate substrates (i. 
e., nearly equal Vmax) was interpreted to suggest that addition to the 
phosphorus atom is not rate limiting among the reaction steps. Lastly, 
single turnover experiments failed to trap a pyruvate in the PEP mutase 
reaction. 
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Work in our laboratory has focussed on the metabolism of an 
obscure but important class of natural products, the phosphonates [for 
reviews on this topic see Hilderband.1 Unlike the phosphates, which 
comprise the principal class of naturally occurring phosphorus 
compounds, phosphonates contain a P-C linkage. The phosphonate P-C 
bond is resistant to the acid, base and enzyme catalyzed hydrolysis 
reactions that lead to P-0-C bond cleavage in organophosphates. A 
diverse group of microbes and invertebrates have retained, or specially 
developed, the ability to form the P-C bond and hence, the ability to 
synthesize phosphonates. Because the phosphonyl moiety of the 
phosphonates resemble, both structurally and electronically, the carboxyl 
and phosphoryl moieties of cellular metabolites and because the 
phosphonates are resistant to enzyme catalyzed degradation, 
phosphonates are effective anti-metabolites. Of the naturally occurring 
phosphonates discovered thus far, many have been identified as 
antibiotics, antiviral agents, herbecides or hypertensive agents. 
The actual chemistry of P-C bond formation in biological systems 
has alluded researchers since the discovery of the first phosphonate 
natural product thirty years ago.2 This dissertation describes the advances 
we have made in understanding the enzymology of P-C bond formation 
which have emerged from our investigation of the biosynthesis of the most 
ubiquitous of the naturally occurring phosphonates, 2-
aminoethylphosphonate (AEP). Elucidation3 of the AEP forming pathway 
of Tetrahymena pyriformis (see below) ultimately led to the isolation of the 
I 
P-C bond forming enzyme, PEP mutase from this organism. 4 ,5 Also 
describe herein are studies which examine the chemical mechanism of the 
PEP mutase catalyzed conversion of PEP to phosphonopyruvate. We first 
addressed the question of whether the rearrangement occurs 
intermolecularly or intramolecularly. After demonstrating that an 
intramolecular pathway is followed, we employed stereochemical 




Phosphorus is found in a variety of compounds and plays crucial 
roles in the earth's geology, in biological systems, and in modern society. 
The wide variety of phosphorus compounds is a result of its ability to exist 
in the +5, +3, and + 1 oxidation states and form stable bonds with many 
elements (H, N, 0, S, C, and halides). In the environment phosphorus is 
predominantly +5 and can be found in over 200 minerals, the most 
abundant of which is Ca(PO4)5F2. 6 The earth's geology maintains a 
delicate balance and supply of phosphorus in the soil and in aquatic 
systems available for use by biological systems via a process called the 
phosphorus cycle . Biological systems require phosphorus, and it is often 
the limiting growth nutrient in aquatic ecosystems. Modern society has 
recognized the crucial role phosphorus plays in the ecosystem and has 
used it in a variety of synthetic forms as fertilizers, animal food stuffs, 
detergents, pesticides and herbicides. 
Phosphorus in biological systems originates from phosphate in the 
soil or water. Biological systems use phosphorus in oxidation states of +5 
(phosphates), +3 (phosphonates, phosphites) , and + 1 (phosphinates). 
Biophosphates in the +5 oxidation ·state assume a variety of forms and play 
many important roles. High energy phosphate ester and anhydride 
moieties in some biophosphates, like phosphoenol pyruvate (PEP) and 
adenosine triphosphate (ATP), are important in bioenergetics. 
Phosphodiester linkages make up the backbone of dideoxyribonucleic acid 
(DNA) and ribonucleic acid (RNA), molecules which are important in 
genetic processing. Phospholipids are important constituents of biological 
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membranes and play important roles in cellular structure. The P-O linkage 
in biophosphates is kinetically and thermodynamically stable, but can be 
manipulated by the correct phosphoryl-transfer enzyme catalyst in order to 
fulfill a given biological function. 
Phosphorus also occurs in lower oxidation state in biological 
systems as phosphonates ( +3) and phosphinates ( + 1 ). Although the 
origins of these more reduced biophosphates are less understood, current 
studies are revealing interesting aspects of their reactivities . 
Phosphonates and phosphinates contain a P-C bond which give them a 
different range of reactivity. The P-C bond is thermodynamically less stable 
than its P-O counterpart.? However, the kinetic barrier for P-C bond 
cleavage is apparently much higher than for P-O bond cleavage. For this 
reason most phosphonates are inert to hydrolysis by strong base (5 M 
NaOH, 120°c for 8 h) and strong acid (8M HCI for 48 h).2 The kinetic 
stability of the P-C linkage also causes phosphonates and phosphinates to 
be inert to transfer reactions catalyzed by typical phosphoryl-transfer 
enzymes. Thus, a class of enzymes different than those which act on 
phosphates is required to manipulate the P-C bond. 
Phosphonates occur in plants, coelentrates, molluscs, echinoderms, 
arthropods, porifera, and mammals. Since phosphorus is found in its +5 
oxidation state in the environment these reduced forms of phosphorus in 
the biota must be produced biologically. Phosphonates are believed to be 
produced only by lower organisms. The existence of phosphonates in 
higher organisms is believed to be the result of dietary intake of exogenous 
phosphonates. In lower organisms phosphonates can make up a 
significant amount of the total phosphorus. Phosphonates make up 50% of 
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the proteinaceous extract of the sea anemone M. dianthus,Bnearly all of the 
phosphorus in Helisoma sp. snail eggs,9 and 13% of the total phosphorus 
in the protozoa, Tetrahymena pyriformis W.1 o The large amount of 
phosphonates suggests they play important physiological roles in these 
organisms. 
In living organisms phosphonates are found in a variety of forms. In 
a broad sense, phosphonates can be classified functionally as either 
structural units, phosphonolipids, or as secondary metabolites, antibiotics. 
The most abundant and ubiquitous phosphonate is 2-
aminoethylphosphonic acid (AEP). AEP is found both in lipids and in the 
free form.11 Some examples of phosphonoliplds are 
glycerophosphonolipids and sphingophosphonolipids which occur in 
nervous tissue of animals12 , in sea anemone 13, in rumen protazoa14, and 
in parasitic organisms Bdellovibrio bacleriovorus15 and Pythium 
prolatum. 16 A number of Streptomycetes species produce phosphonate 
secondary metabolites. Fosfomycin and forms of 3 -N-
acyaminopropylphosphohates are produced by strains of 
Streptomycetes. 17 Fosfazinomycins A and B, produced by Streptomycetes 
lavendofoliae, 1 B are potent antifungal agents. Bialaphos is produced by 
Steptomyces hygroscopicus19 and is unique in that it contains a 
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Although the physiological roles of ph
osphonates are not well 
understood, some researchers have post
ulated functions for phosphonates 
in living systems. The function of phos
phonates must be related to the 
different reactivity of the P-C bond, rel
ative to the P-O bond. AEP is 
believed to function as a slow-release form
 of phosphate in maturing eggs 
of the Helismoa sp. snail eggs.
9 AEP has apparently no active 
physiological function other than to serv
e as a precursor to structurally 
more complex phosphonates. AEP 
is the phosphonate containing 
constituent in phosphonolipids. The P-C
 bond is kinetically more stable 
than a P-O bond and is resistant to acid
 and base hydrolysis. Therefore , 
unlike P-O bond-containing phosph
olipids, P-C bond-containing 
phophonolipids are rather inert to enzy
matic hydrolysis, oxidation, and 
other metabolic processes. 
11 Thus, organisms which contain 
phosphonolipids in their cell membrane
s may have an advantage over 
organisms which do not. In light of this
, phosphonolipids are thought to 
bestow parasitic capability on their par
ent organism, allowing them to 




Some organisms produce phosphonates as secondary metabolites 
which have potent antibiotic activity. Fosfomycin and 3-N-
acylaminopropylphosphonate derivatives are antibiotics because they 
inhibit bacterial cell wall biosynthesis.20 Bialaphos is an effective 
herbicide. It is not known whether these secondary metabolites are 
produced intentionally as active antibiotics or are produced for another 
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Many synthetic phosphonates also have potent biological activity. 
Some phosphonates are essentially phosphorus containing xenobiotics 
which influence phosphorus metabolism because they are unreactive 
structural and electronic mimics of physiologically important phosphates. 1 
Phosphonates have been used as insecticides (trichloronate), herbicides 
(glyphosate, fosamin), and plant growth regulators (ethephon). Alkyl- or 
aryldiesters of phosphonic acids are potent inhibitors of biological 
7 
esterases. Trichloronate inhibits acetylcholine esterase and is an effective 
insecticide. Sarin, Soman, Tabun, and VX are phosphonate containing 
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Synthetic phosphonates are starting to replace phosphates in 
industrial applications. Phosphonates are now being used in many 
applications such as adhesives, antioxidants, detergents, flame retardants, 
and lubricants. For practical reasons phosphonates are considered more 
attractive than their phosphate counterparts because of their greater 
hydrolytic stability, lower molecular weight, and lower boiling points. 
8 
Man's increasing use of phosphonates instead of phosphates may 
result in the build-up of phosphonate pollutants if nature does not have a 
mechanism to catabolize the C-P moiety. The natural occurrence of 
phosphonates, however, indicates that nature has methods for 
manipulating C-P bonds. Indeed, researchers have found some organisms 
which can cleave a P-C bond and some organisms which can form a P-C 
bond. Studies of both P-C bond cleavage and formation have important 
practical applications. Studies into P-C biosynthesis have at least one 
important practical goal, that is the design of a selective agent against 
phosphonolipid containing parasites. Studies of bacterial C-P bond 
cleavage may lead to a biological means of controlling potential 
phosphonate pollutants. 
II. Biological Pathways of P-C Bond Cleavage 
Phosphonates have the potential to be persistent pollutants since 
the P-C bond is highly resistant to the ecological forces of chemical 
hydrolysis, photolysis, and oxidation. Fortunately, there are two known 
biological pathways to P-C bond cleavage in nature. Certain bacteria are 
able to cleave the P-C bond by either an AEP-specific degradation 
pathway involving the enzyme phosphonoacetaldehyde hydrolase 
(hereafter referred to as phosphonatase), or by a substrate-nonspecific 
system involving the enzyme C-P lyase. Both of these P-C bond cleaving 
systems are induced in bacteria under phosphate starvation conditions, 
and the P-C bond cleaving phenotype is not expressed when phosphates 
are available.21-23 Since such phosphate starvation conditions are not 
9 
.. 
typically found in nature, these bacterial systems have limited di
rect utility 
as environmental clean-up agents. Hence, there has been an
 intense 
research effort to better understand their mode of action in the 
hope that 
either purified enzyme catalyst or engineered bacteria can be
 used to 
degrade otherwise environmentally persistent phosphonate pollut
ants. 
A. AEP Biodegradative Pathway 
The AEP degrading system was first discovered in B. cerius by 
La 
Nauze.24 As illustrated in Scheme 1 the pathway consist
s of two 
enzymatic reactions. AEP is first converted to phosphonoacetald
ehyde by 
AEP transaminase. Phosphonoacetaldehyde then serves as the 
substrate 
for phosphonatase. AEP transaminase, the first enzyme of the 
pathway, 
was purified and characterized by Demora
25 in 1984, and requires 
pyruvate as an amine acceptor and pyridoxal phosphate as a cofac
tor. The 
second enzyme, phosphonatase
26 •27 , requires a divalent metal for 
structural, not catalytic purposes, and converts phosphonoacetald
ehyde to 
phosphate and acetaldehyde. 



























B. The C-P Lyase Pathway 
C-P lyase is a substrate-nonspecific enzyme system found in several 
bacteria including K. pneumoniae, A. radiobacter, Agrobacterum, E. coli, 
and K. ascorbata. C-P lyase can cleave P-C bonds in which the 
phosphonate carbon substituent is not funtionalized. 28-35 The C-P lyase 
system converts phosphonates to phosphate and the corresponding 
alkane (Scheme 2). C-P lyase is far less understood than the AEP 
degradation system in which the mechanisms of the isolated enzymes are 
understood in some detail. 
Scheme 2. The Reaction Catalyzed in the C-P Lyase Pathway 
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C. Enzymology of P-C Bond Cleavage 
alkane 
In order to understand the possible mechanisms of P-C 
bond cleavage by phosphonatase or C-P lyase several chemical models 
for the cleavage of functionalized and nonfunctionalized phosphonates will 
be discused. 
1. Chemical Models for P-C Bond Cleavage 
Phosphonates functionalized on the alpha or beta carbon typically 
undergo heterolytic P-C bond cleavage. Heterolyic cleavage of the P-C 
bond produces a carbanion leaving group which must be stabilized by 
] ] 
electron withdrawing subtituents. For exam
ple, trifluoromethyl 
phosphonate readily hydrolyzes 
under alkaline conditions.a 6 
Phosphonates functionalized on the a
lpha carbon with a hydroxyl group 
can undergo P-C bond cleavage unde
r alkaline conditions by migration of 
the phosphorus atom from carbon 
to oxygen followed by P-O bond 
cleavage. 37 These reactions are illustr
ated in Scheme 3. 







































Functionalization at the beta carbon fa
cilitates P-C bond cleavage 
via a f3-elimination process, Scheme
 4. The plant growth regulator 
Ethephon, having a chlorine on the bet
a carbon, rapidly decomposes in the 
presence of hydroxide ion to form ph
osphate, chloride and ethylene.38 
1 2 
The hydrolysis of P-keto phosphonates has also been studied. The P-C 
hydrolysis of p-keto phosphonates is catalyzed by chelation of a divalent 
metal cation with the ketone. P-C bond hydrolysis is also catalyzed by 
Schiff base formation at the beta carbon.24 Martel and coworkers39 have 
demonstrated that the pyridoxal Schiff base of 2-amino-3-phosphono-
propionic acid (P-ala) undergoes C-P bond cleavage in the presence of 
Cu+2 under mild conditions (95°C, pH 7.5). 












Phosphonates which are not functionalized at the alpha or beta 
carbon can be cleaved via a homolytic P-C bond cleavage, thus avoiding 
the high energy carbanion intermediate produced by a heterolytic 
cleavage. A model proposed for this reaction is the lead(IV) tetraacetate 
transformation of phosphonates to phosphate and the corresponding 
alkane. Frost and coworkers40 postulated the mechanism involved 
formation of an oxyl radical followed by P-C bond cleavage producing a 
carbon-centered radical and monomeric metaphosphate. The existence of 
the carbon-centered radical intermediate was evidenced by reacting the 
cyclopropylmethylphosphonate (1) with tert-butylthiol and AIBN 
(azobisisobutyronitrile) which produced methylcyclopropane and 1-
butene .41 The 1-butene could only be produced from the putative 
cyclopropylmethyl radical intermediate. Monomeric metaphosphate was 
trapped as t-butylphosphate when 4-methylbenzylphosphate was reacted 
with tributytin hydride followed by the addition of tert-butanol. These results 
are summarized in Scheme 5. 
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2. The Mechanism of Phosphonatase 
Dephosphonylation beta to a carbonyl can be considered 
analogous to a ~-keto decarboxylation process (Scheme 6), where the C-C 
bond is activated for cleavage and the departing enolate is stabilized either 
by divalent metal cation chelation or by Schiff base formation. 42 La Nauze 
reported that the required magnesium cofactor did not chelate to P-Ald and 
therefore probably does not play a direct role in catalysis.26 The 
magnesium is postulated to be necessary for maintaining the active dimeric 
enzyme structure. P-Ald was found to form a Schiff base with the enzyme 
during catalysis. La Nauze26 was able to trap the P-Ald/enzyme or 
acetaldehyde/enzyme Schiff base by reducing it with KBH4, thus 
irreversibly inactivating the phosphonatase. These result are consistent 
with the general mechanism for phosphonatase shown in Scheme 7. 





Scheme 7. Catalytic Mechanism of Phosphonatase. 
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Olsen et al. showed the inactivation event occurred at the active site 
by demonstrating that inactivation could be blocked by the substrate 
analog, acetonylphosphonate. 43 Furthermore , the active site res idue 
responsible for Schiff base formation was identified as a lysine residue and 
the active site tryptic peptide was sequenced (Scheme 7). 
To further detail the C-P cleavage event the stereochemical course 
of the reaction was determined. The hydrolysis of the C-P bond of 
[170, 1BQ]thiophosphonoacetaldehyde (SP-Aid) in H2160 resulted in the 
phosphorus streochemistry being retained in the thiophosphate product 
(Scheme 8).44 Two mechanistic possibilities consistent with these results 
are shown in Scheme 9; two in-line displacements of the thiophosphoryl 
group (pathway a) or adjacent nucleophil ic attack followed by 
pseudorotation (pathways b and c). To date there is no evidence to 
I 7 
support the existence of a second active site nucleophile which is required 
for the double displacement mechanism. 
Scheme 8. The Stereochemical Course of Phosphonoacetaldehyde 
Hydrolase 
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The adjacent attack mechani
sms involving either the carb
onyl 
oxygen or a water molecule also
 seem unlikely. P-Ald with 1ao label
 in the 
carbonyl was dephosphonylate
d with phosphonatase and the
 phosphate 
produced did not contain the 
180 of the carbonyl. The adjacen
t attack by 
water (pathway c) followed by p
seudorotation was explored by 
determining 
the solution hydrolysis of chiral [1
80JTP-Ald. 
It was reasoned that if the fac
tors necessitating putative adja
cent 
attack in the enzyme were due o
nly to the Schiff base formation, 
then Schiff 
base formation in the solutio
n hydrolysis should produce 
the same 
retained stereochemical result. 
The factors which govern adjac
ent versus 
in-line attack are outlined by W
estheimer's rules. 
45 Westheimer's rules for 
nucleophilic displacement at p
hosphorus predicts that the n
ucleophile 
must approach in the apical d
irection opposite the most elec
tronegative 
group, and the departing ligand
 must leave from an apical pos
ition of the 
pentavalent trigonal bipyramid i
ntermediate. Since the apical p
ositions are 
preferentially occupied by the m
ost electronegative groups, the 
nucleophile 
must approach opposite the m
ost electronegative group. Us
ing these 
paradigms, one predicts that the
 hydrolysis of a P-C bond would
 occur with 
water attacking opposite oxygen
 (or sulfur) and adjacent to carb
on to form 
a pentavalent intermediate. Th
is trigonal bipyramid intermedia
te (4) then 
must undergo one pseudorotati
on event to place the carbon le
aving group 
in an apical position for departu
re (5). Following the sequence
 of steps of 
pathway c in Scheme 9, 
one can easily see that thi
s adjacent 
attack/pseudorotaion mecha
nism retains the original p
hosphorus 
stereochemistry in the product. 
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If this adjacent attack mechanism is the cause of the retention of 
phosphorus stereochemistry observed in the phosphonatase reaction , then 
the same stereochemical result should be observed in the Schiff base 
mediated reaction in solution. So, to better interpret the retained 
phosphorus stereochemistry observed for phosphonatase, Lee et. al.44 
determined the stereochemical course of the solution hydrolysis of chiral 
SP-Aid. The chiral thiophosphate produced from the aniline catalyzed 
hydrolysis of chiral SP-Aid was found to have inverted phosphorus 
stereochemistry (Scheme 10). A single in-line displacement mechanism 
would invert the stereochemistry. 
Scheme 10. Aniline-Catalyzed Solution Hydrolysis of P-ald 
Q 








Therefore, these results are consistent with an in-line attack of water 
opposite the the Schiff base carbon leaving group. If the solution 
hydrolysis of a P-iminophosphonate involves an in-line attack, there is no 
reason to invoke an adjacent attack/pseudorotation mechanism for the 
phosphonatase-catalyzed hydrolysis. Experiments designed to gain 
evidence for the double-displacement mechanism involving a second 
enzyme nucleophile are now in progress. 
3. Mechanism of C-P Lyase 
The mechanism of C-P lyase is not well understood. The 
nonfunctionalized carbon would preclude the operation of a 
phosphonatase-like reaction, since the heterolytic C-P cleavage would 
result in a very high energy carbanion . Therefore, researchers have 
postulated a homolytic bond cleavage mechanism consistent with the 
chemical model studies. 
The C-P lyase activity has yet to be demonstrated in vitro, therefore 
all mechanistic details of C-P lyase are based upon in vivo studies. Walsh 
and coworkers have demonstrated that a radical intermediate may be 
involved in the C-P lyase reaction .22 Walsh used two radical probes, 
cyclopropyl methylphosphonate (6) and cis-1,2-
dideuteropropenylphosphonate (7). If homolytic P-C bond cleavage 
occurs cyclopropyl methylphosphonate should produce a 
cyclopropylmethyl radical, which rearranges to 1-butene at a rate of 108 
s-1. If homolytic bond cleavage of cis-1,2-dideuteropropenylphosphonate 
occurs, the resulting cis-1,2-dideuteropropyl radical which rearranges to 
the trans-1,2-dideuteropropyl radical at a rate of 109 s-1 would produce 
2 1 
trans-1,2-dideuteropropene. C-P lyase produced 0.3-2% 1-butene from 
cyclopropyl methylphosphonate and 1 .5% trans-1,2-dideuteropropene 
from cis-1,2-dideuteropropenylphosphonate. These results are 
summarized in Scheme 11. The small amount of rearranged product 
indicate either a very short-lived radical intermediate, or radical cleavage is 
not the major reaction pathway. 
Scheme 11. Probes for a Radical Mechanism in C-P Lyase 
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Walsh and coworkers attemp
ted to characterize the C-P l
yase gene 
in the hope that C-P lyase ac
tivity could be reconstituted i
n vitro. The C-P 
lyase operon has 17 open r
eading frames encoding 17 
proteins. 46 Thus 
the C-P lyase activity is the r
esult of a complex multi-prote
in system, which 
remains undefined. 
The application of knowledg
e gained by the research of
 biological 
C-P bond cleavage may 
eventually lead to an effi
cient means of 
biodegradation of phosphona
tes. Thus far the study of C-
P bond cleavage 
has produced intriguing i
nsight into the enzymolog
y of P-C bond 
manipulation. The cryptic 
nature of C-P lyase and th
e still not fully 
understood detailed mechan
ism of phosphonatase will p
rovide scientists 
much work in the future. 
11. P-C Bond Formation in
 Nature 




ates are formed. How can t
he knowledge of 
biological P-C bond formatio
n be utilized in a constructiv
e manner? As 
mentioned earlier, there are 
numerous naturally occurring
 phosphonates, 
some of which have potent b
iological activity. Most natur
al phosphonates 
are found bound in lipids. P
hosphonolipid constituents g
ive a membrane 
stability against lipases and
 chemical hydrolysis. There
fore, organisms 
with phosphonolipid constitue
nts in the cell wall have the 
ability to exist in 
somewhat harsh environmen
ts. The parasitic capability 
of some rumen 
protazoa,47 a. bacteriovorus, 15 and pythea
 fungus1
6 is attributed to their 
ability to make phosphonol
ipids. Evidence linking ph
osphonolipids to 
23 
parasitic capability can be found in the case of B. batriovorus. 15 This 
microbe can be either saprophytic or parasitic, having the unique ability to 
live inside other bacteria. Interestingly, only strains which make 
phosphonates are parasitic. The phosphonolipid-containing protozoa, 
Tetrahymena pyriformis, are facultatively parasitic and infect a variety of 
aquatic invertebrates Another organism in which phosphonate appear to 
bestow parasitic capability is the fungus Pythium pratum. Ceramide AEP is 
found in both major genera of Pythiaceae fungus, the only fungus known to 
have phosphonolipids. The Pythiaceae are plant pathogens of enormous 
importance to nearly every economic agricultural crop. 
Therefore, understanding the mode of phosphonolipid synthesis, 
especially the mode of P-C bond formation, could lead to the design of 
specific antiparasite reagents, such as a Pythiaceae fungicide. Over the 
past 25 years several groups have been investigating the mode of P-C 
bond biosynthesis. The following sections will describe work which has 
been done in elucidating the biosynthesis of AEP, fosfomycin, and 
bialaphos. 
A. AEP Biosynthetic Pathway 
Phosphonates were first discovered in biological systems in 1959 by 
Horiguchi and Kandatsu 8_ These same workers later identified AEP as the 
major phosphonic acid unit, existing both in the tree form 7 and bound in a 
lipid form 4. Free AEP was first proposed to be derived from lipid-bound 
AEP because [32PJ phosphate ([32PJ Pi) was incorporated more rapidly into 
lipid-bound AEP than free AEP. Lipid-bound AEP would be formed by a 
mechanism outlined in Scheme 12. 
24 








However, subsequent experiments discounted this hypothesis. First, 
a pulse-chase experiment in which log phase cells were incubated first 
with [32 P] Pi for one hour followed by a chase with inorganic phosphate 
revealed no loss of radioactivity from lipid-bound AEP. Therefore, lipid-
bound AEP was not labile and not the precursor to free AEP. Second, a 
two hour incubation of log phase cells with [32P] Pi resulted in [32P] lipid 
AEP having greater radioactivity than [32p] phosphate lipid11 . Thus, the 
phosphoryl group in AEP was not derived from a phospholipid. Finally, 
Horguchi and coworkers demonstrated the conversion of [32P] Pi to AEP in 
a cell-free homogenate of Tetrahymena and showed that AEP was 'free' 
and not lipid-bound 48 . An explanation for the original observation of [32P] 
25 
Pi being incorporated into lipid-AEP faster than into free AEP may be that 
there is a pool of free AEP and newly synthesized AEP is channeled more 
directly into lipid synthesis. 
Mounting evidence indicated the C-P bond was not derived by the 
mechanism in Scheme 13, so alternative mechanisms were proposed 
which incorporated the finding that phosphoenol pyruvate was a direct 
precursor to AEP. In vivo studies carried out by Trebst and Geike 
implicated PEP was a direct precursor to AEP 49. Utilizing 14C glucose the 
authors showed that C-1 and C-2 of AEP were derived from C-1 and C-2 of 
glucose, respectively. Laing and Rosenberg showed that T. pyriformis 
converted [14C-1 or 14C-2] glucose into [14C-1] AEP so. In addition to 
these results, Warren showed that [14C-3 or 14C-4] glucose lead to no 
incorporation of 14C into AEP. 
Warren also demonstrated the conversion of [32P] PEP to [32P] AEP 
with a 0.0007% yield in a system of a cell-free homogenate of Tetrahymena 
pyriformis W. 51 Accompanying [32p] AEP was the formation of [32P] 
phosphonoalanine (P-ala) 5. P-ala could be subsequently converted to 
AEP in a 0.04% yield, implicating it as a possible intermediate between 
PEP and AEP. (Scheme 13, pathway b). 
An alternative mechanism for AEP formation, employing PEP as a 
precursor, was proposed by Horiguchi and coworkers 52_ They proposed, 
contrary to Warren's mechanism, that P-pyr was first decarboxylated to 
phosphonoacetaldehyde (P-ald) 6 and subsequently transaminated to 
form AEP (Scheme 13, pathway a). 
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Scheme 13. Proposed Pathways for the Biosynthesis of AEP in T. 
pyriformis. 
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Evidence supporting pathway a , decarboxylation followed by 
transamination , was provided by Horiguchi and coworkers.52 A 
radiolabel dilution study examined the ability of unlabeled P-ala or P-ald to 
dilute the incorporation of [32P] from PEP into AEP . Under optimal 
conditions Horiguchi could incorporate 0.34% of [32p] from 150 nmol [32P] 
PEP into AEP. However, if three equivalents of unlabeled P-ald (750 nmol) 
were added , incorporation of radiolabel diminished to 0 .021 %. 
Conversely, three equivalents of unlabeled P-ala decreased incorporation 
only to 0.29%. Therefore, the authors concluded on the basis of those 
results that P-ald was the direct precursor to AEP and P-ala 
decarboxylation was, at most, only a minor pathway to AEP. 
The intermediates in the pathway, P-pyr and P-ald , were never 
directly observed but Horiguchi did claim to trap them as hydrazone 
derivatives. [32p] PEP (0.017 mmol) was incubated with cell-free extracts 
2 7 
of T. pyrifomis which were subsequently treated with 2 ,4-
dinitrophenylhydrazine and subjected to hydrogenolysis. The hydrazone 
derivative of P-pyr and P-ald should yield P-Ala and AEP, respectively, 
upon catalytic hydrogenation. Chromatography of the reaction mixture 
resulted in radiolabeled material coincident with authentic P-ala and 
AEP.53 However, these derivatives were not further characterized. In a 
more recent report Takada and Horiguchi claimed to have trapped P-pyr as 
a hydrazone derivative using non-radiolabeled PEP. 
Phosphoenolpyruvate was incubated with 24 gm of a cell-free homogenate 
of T. pyriformis which was subsequently treated with 2,4-
dinitrophenylhydrazine. Chromatography of the reaction mixture yielded 
two compounds which were coincident with authentic P-pyr and P-pyr-2,4-
dinitrophenylhydrazone. Catalytic hydrogenolysis produced a ninhydrin-
positive substance which was indistinguishable from P-Ala on cellulose 
TLC analysis.54 
The mechanism of the presumed PEP to P-pyr conversion was 
probed by Horiguchi and Rosenberg.53 By using doubly-labelled PEP they 
set out to test whether or not P-pyr formation occurred via an intra- or 
intermolecular reaction of PEP. They observed that doubly-labelled [32P], 
[14C-3] PEP (consisting of 991 nmol of phosphoenol-[14C-3]pyruvate and 
48 nmol [32P] PEP) was converted to AEP (0.013%) and P-ala (0.0022%) 
having the same 14C/32P ratio of the starting material. These results were 
consistent with an intramolecular rearrangement. 
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B. Phosphonate Antibiotic Biosynthetic Pathways 
The biosynthetic pathways of two phosphonate antibiotics have 
been the focus of intense research . Fosfomycin is an antibiotic produced 
by various strains of Streptomycetes at the end of their log phase growth. 
Fosfomycin works by inhibiting bacterial cell wall biosynthesis by alkylating 
a thiol group in the active site of phosphoenolpyruvate : UDP-Glc-NAc-
enolpyruvyl transferase.55 Current knowledge of the biosynthetic pathway 
of fosfomycin is presented in Scheme 14. The C-P bond in fosfomycin is 
believed to be derived from the same pathway responsible for AEP 
synthesis. Glucose labelled in the 1- or 6- position with 13C produced 
[13C-1]fosfomycin and [13C- 2]glucose produced [13C-2]fosfomycin.56 The 
C-3 methyl group of fosfomycin was derived from S-adenosyl-L-
methionine.57 These results indicate the P-C2 unit most likely comes from 
a rearrangement of PEP to phosphonopyruvate followed by 
decarboxylation to P-Ald. 
Scheme 14. Biosynthesis of Fosfomysin. 
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The steps elaborating P
-Ald to fosfomycin, spec
ifically methylation 
and oxirane formation, a
re still not well understoo
d. The methylation of th
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hionine, is precluded due
 
to the electrophilic natur
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Scheme 15. Epoxidation of cis-1 -Propenyl-1-Phosphonate 
8 Fosfomycin 
The biosynthesis of Bialaphos has also been studied . This 
biosynthetic pathway is comparatively more complicated since bialaphos 
contains a phosphorus with two carbons attached to it (a phosphinate). 
The multistep synthesis can be broken down into two basic processes. 
First is the synthesis of phosphinothricine, the phosphinate portion, which 
is an L-glutamic acid analog . Second, two alanine residues are added to 
the carboxyl group of phosphinothricine. Bialaphos contains a unique C-P-
C moiety. The first P-C bond comes from the PEP mutase rearrangement 
of PEP to P-pyr. 61 The second P-C bond is formed by the enzyme 
carboxyphosphonoenolpyruvate (CPEP) mutase.62-63 The biosynthetic 
pathway to bialaphos is shown in Scheme 16. The pathway was 
determined by analyzing the intermediates which accumulated in the 
growth media of mutants which were blocked at different steps in the 
pathway.64 The sequence of the steps was determined by the conversion 
of intermediates to bialaphos by mutants which were blocked at earlier 
steps in the pathway. The enzymes responsible for the formation of the 
two C-P bonds will be discussed later. 
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Scheme 16. The Biosynthetic Pathway of Bialphos 
PEP 
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Typical laboratory syntheses of P-C bonds employ a nucleophilic 
phosphorus in a reduced oxidation state (+3 or +1) and an electrophilic 
carbon. Alternatively, and much less commonly, the electronic demands 
may be reversed, employing an electrophilic phosphorus ( +5) and a 
nucleophilic carbon . Since biological systems overwhelmingly utilize 
phosphorus in its (electrophilic) +5 oxidation state, one anticipates the later 
carbon nucleophile mechanism to be employed in biological P-C 
synthesis. However, some bacteria are able to oxidize phosphite 
3 2 
(nucleophilic , +3 phosphorus) to phosphate .65-67 It is therefore 
conceivable that the reverse of this process could be a source of 
nucleophilic phosphorus species in bacteria. Therefore, the typical mode 
of P-C synthesis involving a +3 phosphorus nucleophile may be possible in 
biological systems. Since both approaches to P-C bond formation are 
possible in biological systems, both modes of laboratory syntheses of P-C 
bond will be described. 
1. Chemical Models for P-C Bond formation via 
Nucleophilic Phosphorus 
Examples of P-C bond formation reactions employing a nucleophilic 
phosphorus are illustrated in Scheme 17 and exemplified by the classical 
Michaelis-Arbuzov reaction employing a trialkylphosphite and an alkyl 
halide. A variation of the reaction is the Perkow reaction which is the 
reaction of a trialkyl phosphite and an a -halocarbonyl compound. The 
course of this reaction can produce either a vinylphosphate and/or a P-
ketophosphonate. 68 Interestingly, these are the two species involved in 
the putative rearrangement of PEP to P-pyr. The product distribution of the 
Perkow reaction is dependent upon the type of halogen , the temperature 
and the polarity of the reaction solvent. In general, the vinyl phosphate 
product formation is enhanced by lower temperature and increased 
electronegativity of the halogen. The mechanism is not entirely 
understood. The P-ketophosphonate product is believed to arise from 
direct displacement of the halogen. The intermediate salt produced does 
not rearrange to the vinyl phosphate. Thus, the vinyl phosphate product is 
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believed to arise from nucleophilic attack at the carbonyl carbon, followed 
by phosphoryl migration to the oxygen and loss of an alkylhalide. 





2. Chemical Models of P-C Bond Formation via 
Electrophilic Phosphorus 
Routes to P-C bond syntheses via a nucleophilic carbon and an 
electrophilic phosphorus are known. These syntheses are base catalyzed 
intramolecular rearrangements of vinyl phosphates to ~-ketophosphonates. 
In 1981 Melvin 69 reported phenylphosphate (9) rearranged to o-
hydroxyphenylphosphonate (10) in the presence of n-butyl lithium or 
lithium diisopropylamide (LOA). Weimer and coworkers70,71 reported 
similar rearrangements of numerous cyclic vinyl phosphates to ~-
ketophosphonates illustrated in Scheme 18. The rearrangement of a 
mixture of (11) and (12) produced only (13) and (14) and therefore the 
rearrangement was an intramolecular process. The rearrangement was 
initiated by the abstraction of an allylic or (in the absence of an allylic) a 
vinyl proton by strong base. 
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No cross-over products formed 
The stereochemical course of the base catalyzed rearrangement of 
an arylphosphate ester to an o-hydroxy phosphonate recently has been 
reported . Welch and coworkers72 reacted pseudoephedrine or ephedrine 
(aryloxy) phospholidine derivatives with lithium diisopropylamide in 
tetrahydrofuran and discovered they undergo P-O (15) to P-C (16) 
rearrangement with retention of configuration. Although the investigators 
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did not speculate on the mechanistic implications, these results are 
consistent with a mechanism which proceeds through a four membered 
ring, pentavalent intermediate that must pseudorotate to form product. 




The rearrangement of a vinyl phosphate to a beta keto phosphonate 
by acid catalysis has also been reported. Machleidt et. al. 73 reported that 
the thermal rearrangement of O,O-diethyl phosphonoacetone (17) to the 
O,O-diethyl enolphosphate (18) occurred to a larger extent in the presence 
of acid. The addition of 2-butanone had no influence on the products 
formed and therefore, the reaction appeared to be an intramolecular 
process (Scheme 20). 
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Understanding the way in which nature creates a P-C bond is 
important for both scientific and practical reasons. From a scientific point of 
view the P-C bond formation in nature is challenging to our present 
understanding of enzyme catalysis. The rearrangement could employ 
either a nucleophilic carbon or a nucleophilic phosphorus, however either 
possibility is somewhat problematic. The general view that PEP directly 
rearranges to P-pyr requires a nucleophilic carbon acid, analogous to the 
carbanions produced in the LOA catalyzed rearrangements of cyclic 
vinylphosphates to p-oxophosphonates. Formation of such a carbon anion 
in PEP seems out of reach for an enzyme. The reported acid catalyzed 
thermal rearrangement may be a better model. Alternatively, the 
phosphorus in PEP could act as the nucleophile if it were first reduced to 
the phosphite. However, there is no evidence for such a reductive step. 
Therefore, the enzyme catalyzed rearrangement of PEP to P-pyr is of great 
chemical interest. 
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From a practical viewpoint the P-C bond formation in nature may 
serve as an attractive target for the design of anti-parasite compounds. It is 
believed that some parasitic organisms rely on phosphonolipids to be able 
to live inside other organisms. Since only a select few organisms can 
synthesize a P-C bond, the P-C bond synthetic machinery is a good target 
for the design of inhibitors to control these parasitic organisms. By 
understanding the P-C bond formation involved in AEP (and 
phosphonolipid) biosynthesis, scientists may be able to rationally design a 
molecule to inhibit it, thus killing the parasite. 
The understanding of P-C bond formation in nature and the possible 
development of a phosphonate-dependent antiparasitic reagent were lofty 
goals in 1986. Before 1986 all of the studies of AEP biosynthesis were 
characterized by low yields of AEP, and no phosphonate precursors to AEP 
were ever directly observed, thus making characterization of the pathway 
very difficult. Additionally, attempts by scientists to isolate the P-C bond 
forming enzyme from T. pyriformis or S. hygroscopicus for mechanistic 
studies had not been successful. Our goal was to establish the mode of 
AEP biosynthesis in T. pyriformis and discover the origin of the P-C bond. 
This dissertation describes the progress made in understanding the 
detailed pathway of AEP biosynthesis. Additionally, this dissertation 
describes the discovery, purification, and initial characterization of the 




Our strategy was to fir
st firmly establish the p
athway of AEP 
formation in Tetrahymena
 pyriformis W . by demons
trating the intermediacy 
of P-pyr and P-ald as a re
sult of their ability to be co
nverted to AEP in cell-
free homogenate. This w
o_uld be facilitated if we c
ould increase the AEP 
forming activity in the cell
-free homogenate. If P-py
r and P-ald prove to be 
intermediates, a direct me
thod for assaying PEP mu
tase activity would then 
be developed for its isol
ation. Purified enzyme w
ould then be used to 
characterize the mech
anism of the phosphor
yl transfer. First the 
rearrangement would b
e characterized as eith
er intermolecular or 
intramolecular. If the rea
ction is an intramolecular 
rearrangement then the 
determination a stepwis
e or concerted process 
will be ascertained by 
analyzing the stereochem
ical consequence of the re
arrangement. 
1 • Verification of the
 PEP¢=> P-pyr Mode of P
-C Bond 
Formation 
Since the conversion of P
EP ¢=> P-pyr is common to
 both pathways 
in Scheme 13, we want
ed to demonstrate the p
recursor role of P-pyr, 
thereby strengthening 
the putative PEP¢=> P-py
r mode of P-C bond 
formation. To distinguis
h between the two pathw
ays in Scheme 14 we 
Would examine the interm
ediates and the differing 
cofactor requirements 
for each pathway. Path
way b requires P-ala as 
an intermediate, and 
PYridoxal phosphate (P
LP) could serve as a 
cofactor for both the 
transamination and deca
rboxlyation. However, pa
thway a requires P-ald 
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as an intermediate and would requi re an a.-keto decarboxylase cofactor, 
thiamine pyrophosphate (TPP) , as well as PLP for transamination. 
Therefore , the two pathways can be distinguished by testing the cofactor-
dependent conversion of P-pyr, P-ald, and P-ala to AEP. 
11. Examination of the Catalytic Mechanism of the 
PEP (::) P-pyr Rearrangement. 
If the rearrangement catalyzed by PEP mutase is analogous to other 
phosphomutases it could preceed eithe r by an intramolecular or 
intermolecular rearrangement. This will be determined by reacting PEP 
mutase with an equimolar mixture of isotopically double-labeled substrate 
and unlabeled substrate. The absence of a single labeled crossover 
product would be evidence for an intramolecular rearrangement. 
Assuming the mechanism is an intramolecular process, it could be 
considered as occurring via a stepwise or concerted mechanism (Scheme 
21 ). The most likely stepwise mechanism involves an enzyme nucleophile 
displacing the phosphoryl group, forming an enolate and a phosphorylated 
enzyme intermediate. The enolate could then be phosphorylated on C-3 
forming P-pyr. We reasoned the operating mechanism could, in part , be 
elucidated by knowing the stereochemical consequence of the reaction at 
phosphorus. The stepwise mechanism should result in retention of 
configuration at phosphorus.74 The concerted mechanism should result in 
overall inversion of configuration at phosphorus. Orbital topology dictates 
that [21t + 2a] migrations in the ground state have a Mobius transition state 
and the absolute configuration of the migrating center undergoes 
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inversion. 75 If the rearrangem
ent is a stepwise process, the
 intermediate 
might be trapped by rapid que
nch techniques. 
Scheme 21. Possible lntramo
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RESULTS AND DISCUSSION 
The results and discussion section consists of the two major phases 
of my research on PEP mutase. The first section describes (I) The 
verification of the PEP~P-pyr mode of P-C bond formation in T. pyriformis 
AEP biosynthetic pathway. This section is further divided into the 
determination of the (A) PEP⇒AEP, (B) P-pyr⇒AEP, (C) P-ald⇒AEP 
conversions (D) the discovery of PEP mutase and, (E) the purification and 
characterization of PEP mutase. The second section describes (11) Studies 
of the catalytic mechanism of PEP mutase. This section is divided into 
three parts (A) Is the PEP⇒ P-pyr rearrangement an intramolecular 
process?, (B) The stereochemical course of the PEP mutase reaction, and 
(C) The search for the intermediate in the PEP~P-pyr rearrangement. 
I. Verification of the PEP~ P-pyr Mode of P-C Bond Formation 
The goal of these studies was to locate and purify the enzyme 
responsible for the putative PEP~P-pyr rearrangement. Initial pathway 
studies were directed at gaining convincing evidence for the PEP⇒AEP 
conversion, and examining whether the pathway involved the intermediacy 
of P-ald or P-ala. Results from these studies lead to the purification and 
characterization of the enzyme responsible for the PEP~ P- pyr 
rearrangement, PEP phosphomutase (hereafter called 'PEP mutase' 
[EC 5.4.2.9) as recommended by the International Union of Biochemists).76 
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A. Evidence for the PEP⇒ AEP Conversion in T. 
pyriformis 
A cell-free homogenate of T. pyriformis was obtained from a 6 l 
culture which was grown to a cell density of OD530=0.9. Centrifugation of 
the culture media yielded about 20 ml of cell paste which was 
homogenized in 80 ml of buffer. Reactions containing 20 ml of cellular 
homogenate of Tetrahymena pyriformis W. and an equal volume of a basal 
solution containing 10 mM MgCl2, 20 mM l-alanine, 2.5 mM PlP and 20 
mM PEP (0.6 mmol) were incubated on a gyratory shaker (110 rpm) for 18 
h at 27°C. A control reaction consisting of 20 ml of cell-free homogenate 
and 20 ml of basal solution not containing PEP was run in parallel to 
quantitate endogenous AEP. 
The workup procedure is the same as described by Barry.7 7 
Reactions were quenched with 20% (w/v) trichloroacetic acid (TCA). The 
protein precipitate was removed by centrifugation (2500g for 10 min). The 
TCA was removed by extraction with ether, and the aqueous portion was 
concentrated to 2 ml, and the solution was acidified The reaction products 
were separated by ion exchange chromatography. Phosphoenolpyruvate 
(as well as P-pyr, P-ald, and P-ala) was found in the water eluate of the 
Dowex-50 (H+) column, whereas AEP was eluted form the Dowex-50 (H+) 
by 3 M NH4OH. After concentration, the NH4OH fraction was loaded on a 
Dowex-1 (acetate) column and the AEP removed by elution with 5% acetic 
acid. The eluates were concentrated in vacuo, and redissolved in a 50% 
D2O buffer containing 50 mM K+HEPES at pH 8 for 31 P NMR analysis. 
We assayed the products of the pathway enzymes by 31 P NMR. The 
31 P NMR chemical shifts of phosphonate (1 Oto 25 ppm) are well separated 
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from those of phosphates (5 to -25 ppm). The relative amounts of reaction 
product were quantitated by comparing their integrals with the integral of a 
known internal standard. 
1. Cell-free Homogenate Conversion of PEP to AEP 
We expected the conversion of PEP to AEP would be low since PEP 
is an intermediate in glycolysis, which will be converted by enolase to 2-
phosphoglyceric acid, and hence to 3-phosphoglycerate by 3-
phosphoglucomutase, or be hydrolyzed by phosphatases to inorganic 
phosphate. Both of these side reaction products should be found in the 
Dowex-50 (H+) water fraction. The reaction of PEP with the cell free 
homogenate, as described above, produced a product mixture consisting 
of AEP (0.4%), phosphate (40%), and 2-phosphoglyceric acid and 3-
phosphoglyceric acid (55%). The small but significant conversion of PEP 
to AEP was encouraging. The large amounts of glyceric acids indicated 
glycolytic processes were more effective than those of the AEP pathway. 
2. TPP-Enhanced Conversion of PEP to AEP 
We attempted to increase the activity of the AEP pathway by adding 
thiamine pyrophosphate (TPP) to the reaction mixtures. The choice of TPP 
was based on the following rationale. Pathway a was the most likely of the 
two proposed pathways in Scheme 13 and it requires P-ald to be derived 
from a decarboxylation of P-pyr. Enzymatically, such a ~-keto 
decarboxylation reaction typically requires a TPP cofactor.78 Therefore, we 
expected the conversion of PEP to AEP would be enhanced in the cell free 
homogenate if TPP were added to the reactions. Two reactions were run 
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as previously described. A reaction of the same cell-free homogenate with 
PEP which did not contain TPP converted PEP to AEP in only a 3% yield, 
but an identical reaction in which 2.5 mM TPP was included, produced AEP 
in a 27% yield. These results provided indirect evidence that the AEP 
pathway involved a rearrangement of PEP to P-pyr which underwent a 
TPP-dependent decarboxylation to P-ald which was converted to AEP. 
Both pathways in Scheme 13 involve P-pyr as an intermediate. We 
therefore sought direct evidence for the involvement of P-pyr in the AEP 
pathway. 
B. Cell-free Homogenate Conversion of P-pyr to AEP 
Having demonstrated efficient TPP-dependent conversions of PEP 
to AEP we felt we could test directly the precursor role of P-pyr. The 
reaction conditions were the same as those described for the conversion of 
PEP to AEP except 9.5 mM P-pyr was used in place of PEP. P-pyr and 
PEP were found in the Dowex-50 water fraction The cell free homogenate 
containing PLP, L-alanine, and Mg2+ could converted P-pyr to AEP in a 4% 
yield. The same reaction mixture when supplied with 2.5 mM TPP 
produced 8% AEP from P-pyr. The conversion of both PEP and P-pyr to 
AEP and the fact that both conversions are dependent on TPP provided 
convincing evidence that the PEP<==>P-pyr rearrangement was indeed the 
source of the P-C bond in the AEP biosynthetic pathway. Although these 
results strongly suggested the operation of pathway a in Scheme 13, we 
wanted direct evidence that P-ald (pathway a) and not P-ala (pathway b) 
was the immediate precursor to AEP. 
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C. Cell-free Homogenate Conversion of P-ald to AEP 
The ability of the cell free homogenate to convert P-ald to AEP was 
examined. The reaction contained a cell-free homogenate of T. pyriformis 
and Mg2+, PLP, D,L-alanine with 0.60 mmol P-ald. Unreacted P-ald would 
be found in the Dowex-50 water fraction . 31 P NMR analysis revealed that 
the reaction produced 43% inorganic phosphate, and 27% AEP. These 
data give strong evidence that P-pyr is decarboxylated to P-ald and P-ald is 
transaminated to AEP. Thus pathway a in Scheme 13 is the major 
pathway to AEP. 
D. Discovery of PEP Mutase 
1. Relative Conversions of PEP, P-pyr, and P-ald to 
AEP 
The relatively low yield of AEP (8%) from P-pyr with respect to PEP 
(27%) and P-ald (27%) was disconcerting. The unexpected lower yield of 
AEP from P-pyr may have been due the fact that the PEP, P-ald, and P-pyr 
reactions were carried out separately, using different batches of cell-free 
homogenate. We decided to further detail the pathway by determining the 
relative conversions of PEP, P-pyr and P-ald to AEP using the same cell 
free homogenate. Four trial were run with different cell batches. We 
expected the highest conversion from P-ald since it lies closest to AEP in 
the pathway and requires only one enzymic transformation. The lowest 
conversion should be observed from PEP since its conversion to AEP 
requires three enzyme transformations. The results of these four trials are 
shown in Table 1.3 
46 
' ' 
Table 1:3 Conversion of proposed intermediates to AEP. 
AEP Isolated [µrrol}perrert (X)l'N8fSion 
Recdarf Trial 1 Trial 2 Trial3 Trial 4 
N.Te3 4µrrol 6µrrol 5µrrol Oµrrd 
PEP [200 µmoij 12 µmoV6% 25µmoV13% 75µmoV37% 36µmoV18% 
P-pyr [130-200 µmol]b 11 µmoV8% 10 µmoV11% 10 µmol/8% 22µmoV16% 
P-ald [200 µmoij 19 µmoV9% 133 µmoV66% 166µmoV83% 80µmoV40% 
aThese are control reactions to which the addition of the PEP, P-pyr and P-ald had been 
omitted . 
bThe trial 1 reaction mixture contained 130 mmol, trial 2 and trial 3 reaction mixtures 
contained 136 mmol and trial 4 reaction mixture contained 200 mmol. 
In every case P-ald gave the highest conversion to AEP. Similar to 
the original observations, the conversion of PEP was consistently higher 
than P-pyr. These results indicate that there are other pathways which 
compete for P-pyr, and that these pathways must be more predominant 
than the pathways which compete for PEP. These results also seem to 
indicate that P-pyr formed from PEP does not readily dissociate from the 
AEP pathway enzymes. Therefore, the decarboxylase may not readily bind 
free P-pyr, thus making it succeptible to degradation before it can be 
converted to AEP. The possibility that the pathway enzymes are coupled is 
consistent with our failure to observe P-pyr and P-ald as products from the 
reaction of PEP. These low conversions of P-pyr to AEP prompted us to 
investigate the other pathways reponsible for the fate of P-pyr in the cell-
free homogenate. 
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2. Determining the In Vitro Fate of P-pyr in the Cell-Free 
Homogenate. 
It was necessary to determine the degradation products of P-pyr in 
the cellular homogenate so that enzymes competing for P-pyr might be 
removed or inhibited. In order to determine the degradation products of P-
pyr in the cellular homogenate short-term reactions were carried out as 
previously described except the AEP pathway cofactors, TPP and PLP 
were omitted and the reaction time was 10 min. The crude product mixture 
was worked up as before, with the exception that the products were not 
separated by chromatography . Identification and quantitation of 
phosphorus species were carried out using 31 P NMR techniques. Within 
10 minutes P-pyr had been totally degraded into inorganic phosphate (3.2 
ppm), and minor amounts of other phosphonates (17 ppm and 15 ppm), 
possibly P-ala and phosphonoacetic acid, respectively. Also formed was 
an organophosphate at -0 .17 ppm, possibly PEP from the reverse reaction 
of the phosphomutase. The phosphorus recovered accounted for all the P-
pyr added to the reaction within 5% (Figure 1 ). 
The identity of the phosphorus species having a 31 P N MR 
resonance at -0 .17 ppm was determined to be PEP by demonstrating its 
conversion to ATP with ADP and pyruvate kinase. Phosphonopyruvate 
(136 µmol) was incubated with the cell-free homogenate and Mg2+ in the 
absence of the pathway cofactors for 20 minutes and the reaction was 
quenched with trichloroacetic acid. The products were chromatographed 
and the 31 P NMR analysis of the Dowex-1 (H+) water fraction indicated P-
pyr had been converted to Pi (60%) plus pyruvate and to PEP (ca. 47 µmol , 
35%) . To one half of the NMR sample was added MgCl2 (20 µmol) , ADP 
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(23.5 µmol), and 54 units of pyruvate kinase (Figure 1 a). After 20 minutes 
the 31 P NMR spectrum was obtained and nearly quantitative formation ATP 
was observed with concomitant loss of PEP at -0.17 ppm and ADP (Figure 
1 b}. These results79 show that PEP mutase in vitro catalyzes the reverse 
reaction, forming PEP from P-pyr. The implication of this result was that the 
PEP mutase activity should be assayed by measuring PEP formation upon 
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Figure 1. 31 P NMR of the products formed from 47 µmol of P-pyr in the 
cell-free homogenate, and 23.5 µmol of added ADP. b) The same reaction 
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d the purification 
of PEP mutase. 
Studies of the kine
tic and catalytic m
echanisms were 
carried out in the P-
pyr⇒PEP direction. 
1. Purification o
f PEP Mutase 
The original purific
ation procedure for
 PEP mutase was 
developed 
in our laboratory 
by Elise Bowman 





 The modified 
Procedure is prese
nted here. T. pyrif
ormis cells were ha
rvested near the 
end of log phase g
rowth and frozen a
t -B0°C. The 250 
g of frozen cells 
Were lysed in the 
presence of BSA a
nd protease inhibit
ors by thawing 
followed by blendin
g for 5 min. The ce
ll-free homogenate 
was centrifuged 
at 17000g to remo
ve cellular debris. 




lfate and removed 
by centrifugation 
at 17000g. PEP m
utase was precipita
ted from the cellula
r extract in 70% 
ammonium sulfate.
 Purification by ch
romatography took 




s subjected to a 
DEAE-cellulose co
lumn to remove a
nionic proteins. P
EP mutase was 
fractionated on a p
henyl-Sepharose co
lumn to which it bo
und very tightly. 
The proteins which
 coeluted with muta
se were removed b
y gel filtration on 
5 1 
L_ 
Biogel P-200. The purification process was followed by SOS-PAGE 
(Figure 2) and is summarized in Table 2. PEP mutase purified in this 
manner typically had a specific activity of 20-30 Units/mg protein. 
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Figure 2. SOS-PAGE of the column chromatographic purification of PEP 
mutase. Lanes 2-8 are tubes 90 to96 from the phenyl Sepharose column 
and lanes 9 -19 are tubes 31-41 from the Biogel. column. Columns 1 and 
20 display molecular weight markers. 
The molecular weight of the denatured PEP mutase obtained from 
SOS-PAGE is about 38000 daltons. Elise Bowman determined the 
molecular weight of the native enzyme was 81000 daltons using gel 
filtration techniques, thus concluding PEP mutase was an a.2 dimer. Seidel 
et al. reported the PEP mutase isolated form T. pyriformis was determined 
to be an a.2 dimer using SOS-PAGE and nondenaturing gel filtration 
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techniques .5 However, in every purification of PEP mutase that I 
performed, the purified PEP mutase consisted of two closely-migrating 
protein bands of equal intensity on SOS-PAGE. This may have been due 
to the action of proteases although we took the extra precautions of having 
protease in inhibitors in the dialysis solution, and subsequently, performed 
all three column chromatographies within 30 h. Alternatively, the PEP 
mutase may be an a.p dimer, consisting of subunits of similar but not equal 
size. However, the N-terminal sequence analysis reported by Seidel et al. 
would suggest otherwise. 5 Thus either my preparations contained a 
contaminating protein or one subunit was unstable to partial proteolysis. 
The kinetic mechanism, metal ion cofactor specificity, and pH 
dependence of purified PEP mutase were determined by Jeff Scholten.4 
The kinetic mechanism is a rapid equilibrium ordered reaction, with P-pyr 
binding both following and tightening metal cofactor binding. PEP mutase 
was found to be activated by several metals. The activations relative to 
magnesium were Mg2+ (1 .0), Co2+ ( 0.5), zn2+ (0.4), and Mn2+ (0.3) . The 
pH effects on the Vm showed no ionizable groups in the range of pH 5 to 9, 
which might act as acid-base catalysts. The plot of Vm!Km vs pH showed 
that catalysis is slowed at acid and alkaline pH. The researchers thus 
concluded that substrate binding is inhibited by the protonation of a group 
with an apparent pKa of about 6.4 and deprotonation of a second group 
pKa 8.4. or, the ionizing groups are acting as acid-base catalysts but are 
not apparent in the Vm vs pH profile due to subsequent rate-limiting step 
such as product release. 
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Table 2: Purification of Phosphoenolpyruvate Mutase 
Total protein total units specijc oc:tivity 
Step (mgT) (moVmin) [moVmin-mg of protein] %yield 
250g cell extroc:t 32000 1320 0.041 100 
15%{wlv) strepbmyci,e 1200 91 
suttate 
~ 4 froc:ton 1020 77 
(45-70%) 
DEAE-<:ellubse 1227 743 0.61 41 
phenyl-Sepharose 12.9 188 14.6 11 
Bo-Gel P-200 3.8 78 20.5 4 







The 31 P NMR data of the conversion of P-pyr to PEP in the cell-free 
homogenate indicated the equilibrium of PEP mutase heavily favored PEP 
formation. We attempted to accurately measure the equilibrium of PEP and 
P-pyr in the presence of partially purified PEP mutase. The approximate 
equilibrium constant for PEP mutase was determined by HPLC separation 
and quantitation of PEP and P-pyr after equilibration with partially purified 
PEP mutase.79 A reaction containing 1 0 mM P-pyr and 1 0 mM PEP, 10 
mM MgCl2 in 160 µI of 50 mM K+HEPES buffer (pH 7.8) was incubated 
with PEP mutase at 25°C. Within thirty minutes the P-pyr absorbance had 
diminished to near baseline, see Figure 3. The ratio of the absorbance for 
PEP (£=2600) and P-pyr (£=1100) was >500:1 . The diminutive amount of 
P-pyr was very difficult to measure. A more accurate value for the 

















Figure 3. HPLC elution profile of a reaction of 1 OmM PEP and 1 OmM P-
pyr in 50 mM K+HEPES buffer containing 1 O mM MgCl2 a) before addition 





PEP is one of the highest energy organophosphate in biological 
systems .80 Approximately 13 kcal/mole of energy is released upon 
hydrolysis owing to the energetically favorable keto formation and 
separation of closely disposed negative charges upon hydrolysis.79 
Therefore, the equilibrium of the phosphomutase was not expected to favor 
PEP. It seemed reasonable to assume the phosphoenol moiety 
rearrangement to the ~-keto phosphonate would behave in an analogous 
fashion to phosphoenol hydrolysis. However, the bond strength of the P-C 
bond in the resulting ~-keto phosphonate was not taken into consideration. 
Published values suggest P-C BDEs are ca. 10-17 kcal/mo! higher in 
energy than P-0 bond dissociation energies.81 The energy obtained from 
the hydrolysis of PEP is only 10-12 kcal/mo I more than the 2-3 kcal/mo! for 
the hydrolysis of phosphate esters-82 Using these data we can estimate 
that ~G for the conversion of phosphonopyruvate to phosphoenolpyruvate 
to be -5 to -7 kcal/mo!. Therefore, considering the relative weakness of the 
P-C bond in phosphonopyruvate one can rationalize the intrinsic 
thermodynamic instability of phosphonopyruvate and the observed 
equilibrium. 
Recently Swalbe et. al.83 reported the equilibrium constant for the 
rearrangement of phosphonopyruvate to phosphoenolpyruvate based on 
theoretical calculations . Energies of optimized structures of the 
tris(cyclohexylammonium) salt of phosphonopyruvate were compared to 
known optimized structures of PEP based upon the PEP monoanion crystal 
structure. Gas phase ~G energies calculated using the MNDO, ST0-3G, 
and 3-21 G basis sets were -6.7, -4.6, and -9.9 Kcal/mo!, respectively, which 
imply the equilibrium constant is at least 2500 in favor of PEP. The authors 
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Channeling is proposed to be operating in pathways to provide efficient 
processing of intermediates which have no other metabolic use other than 
to form the pathway product, for example, antibiotic or protein synthesis. 
Considering the potential toxic nature of some phosphonates and the 
apparent instability of P-pyr, channeling in the AEP biosynthetic pathway 
seems reasonable. Further research into channeling of P-pyr is currently 
being conducted in our laboratory. 
There were two other reports of the purification of PEP mutase. 
Another research group reported purification of PEP Mutase From T. 
pyriformis. Seidel et al.5 reported on purification of PEP mutase by 
chromatography first on DEAE-cellulose then through hydroxylapatite. The 
enzyme was purified 470-fold and had a specific activity of 74 U/mg. The 
kinetic constants obtained were Keat= 41 s-1, Km= 67 µM, and KcatlKm = 
6x1 o5 M-1 s-1. Seto and coworkers61 isolated PEP mutase from a 
bialaphos-producing strain of Streptomyces hygroscopicus. PEP mutase 
obtained from this bacteria was reported to be extremely unstable and 
hence the purification by DEAE-cellulose, hydroxylapetite, and FPLC 
(Mono Q) resulted only in a partially purified enzyme which had a specific 
activity of 15.5 U/mg. 
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I. Studies of the Catalytic Mechanism of the PEP~ P-pyr 
Rearrangement Catalyzed by PEP Mutase 
The focus of our research turned to defining the catalytic mechanism 
of PEP mutase. We intended to carry out experiments to determine if the 
rearrangement catalyzed by PEP mutase was an intra- or intermolecular 
process. Additionally, we wished to determine the stereochemical course 
of phosphoryl transfer during the P-pyr⇒PEP rearrangement. Both of 
these experiments would be carried out in the thermodynamically favored 
P-pyr ⇒ PEP direction rather than the physiological PEP ⇒ P-pyr direction. 
We envisioned both of these studies to involve 31p NMR analysis of 18O-
induced shift perturbations of the phosphorus nuclei in phosphonopyruvate 
and phosphoenolpyruvate. It is well known that a sulfur attached to such 
phosphorus monoesters facilitates such NMR analyses by enhancing the 
shift perturbations caused by an 1 BQ in a nonbridge position on 
phosphorus.85 -8? Therefore , we pursued a synthesis of 
thiophosphonopyruvate (SP-pyr). 
1. Synthesis of Thiophosphonopyruvate 
The synthesis of thiophosphonopyruvate is based upon the 
methodology developed by Tim Hepburn and Sheng-lian Lee in our 
laboratory for the synthesis of chiral thiophosphonates .44 The 
methodology requires a reduced form of phosphate which is derivatized 
with oxyester and amide substituents. If the amide is asymmetric it can 
serve as a chiral auxiliary for the synthesis of a chiral thiophosphonate. 
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The synthesis of thiophosphonopyruvate is shown in Scheme 22. 
Methyl phosphonodichloridothioate (19) is reacted with one equivalent of 
the lithium alkoxide of trimethylsilylethanol followed by one equivalent of 
lithium ( S)-N-methyl methylbenzylamine to form diastereometric N,P-
dimethyl-N-(phenylethyl)-O-[2-(trimethylsilyl)ethyl) phosphonamidothioate 
(22). The P-methyl group then had to be elaborated into the pyruvoyl 
moiety. This was accomplished by a known methodogy88 which involved 
forming the copper enolate of the diastereomers and reacting it with the 2-
tri methylsi lylethyl half ester of oxalylchloride, forming (23) . 
Bisdetrimethylsilylethylation was accomplished using two equivalents of 
cesium fluoride. The phosphonamide was then hydrolyzed under acidic 
conditions, thus producing thiophosphonopyruvate (25). 
2. Substrate Activity of Thiophosphonopyruvate with PEP 
Mutase 
The initial velocities of PEP mutase catalyzed conversion of 
thiophosphonopyruvate to thiophosphoenolpyruvate or 
phosphonopyruvate to phosphoenolpyruvate were measured at pH 8.0 as 
a function of the concentration of pure thiophosphonopyruvate or 
phosphonopyruvate. The thiophosphonopyruvate gave Km= 5 µMand Vm 
= 16 s- 1 values and phosphonopyruvate gave Km= 20 µMand Vm = 24s-1 
values. The lower Km and nearly equal V m values for 
thiophosphonopyruvate vs phophonopyruvate justify its use as a substrate 
for mechanistic studies. The mechanistic implications of these kinetic 
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Then, the phosphoryl group from C-2 is removed , thus reforming the active 
phosphorylated form to the phosphomutase and 3-phosphoglyceric acid. 
Phosphoglycerate isolated from wheat germ carries out and 
intermolecular rearrangement in which the phosphoryl group in the 
substrate, 2-phosphoglycerate, is the same phosphoryl group in the 3-
phosphoglycerate product. It is believed that the intramolecular 
rearrangement is assisted by an active site nucleophile. 
Scheme 23. Intermolecular and lntramolecular Mechanism for 2-
Phosphoglucomutase 
Intermolecular: Animal and Yeast Enzymes 
3-PGA 
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2. Does the PEP Mutase Reaction Proceed 
lntramolecularly? 
We set out to determine whether the reaction proceeded 
intramolecularly or intermolecularly. The two intermolecular mechanisms 
considered are illustrated in Scheme 25. One involves phosphoryl transfer 
from phosphonopyruvate to enzyme bound pyruvate while the second 
requires phosphoryl exchange between two phosphonopyruvate 
molecules bound in a head-to-tail arrangement. Both pathways involve 
transfer of a phosphoryl group from phosphonopyruvate to the pyruvate 
unit of a second reactant molecule. We hoped to distinguish this process 
from the intramolecular phosphoryl transfer reaction by 1 Bo-labelling both 
the phosphoryl group and the C2-carbonyl in one reactant and reacting it 
with a second, unlabelled reactant . Product 1 Bo-labelled at the 
phosphoryl moiety but not at the C2-carbonyl (or vice versa) would signify 
an intermolecular reaction while the absence of cross labelled product 
would give evidence for an intramolecular process. 
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The actual experiment was, as illustrated in Scheme 26, carried-out 
with an equimolar mixture of all 16O-thiophosphonopyruvate (25) and 
thiophosphonopyruvate (26) labelled with one 1 Bo at the thiophosphoryl 
center and one 1 Bo at the C2 carbonyl center. Thiophosphonopyruvate 
was used in place of phosphonopyruvate to simplify analysis of the 1 Bo-
labelled product by 31 P-NMR. We anticipated that we would be able to 
resolve the 31 P NMR resonances for the thiophosphoenolpyruvate 
isotopomers. Our prediction was based upon studies of electron 
distributions in thiophosphates which have demonstrated that the 
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The criterion for an intermolecular process through this 
experimental design is the formation of the cross labelled product [P-1 Bo-
( C-2) ]th iophosphoeno lpyruvate (28) which could only derive from the 
transfer of the thiophosphoryl group of [1602]thiophosphonopyruvate to 
the [18Q-(C - 2)]pyruvate unit originating from [P=18Q,C(2)-
1 BQ]thiophosphonopyruvate (26 ). Likewise, the formation of 
[P= 1 Bo]thiophosphoenolpyruvate (29) in the product mixture would, in 
principal, also demonstrate the operation of the intermolecular mechanism. 
However, as described below, this product can also derive from an 
intramolecular rearrangement of [P= 1 Bo]thiophosphonopyruvate (31) 
generated in situ from [P= 1 Bo, C(2)-1 Bo]thiophosphonopyruvate (26) by 
a competitive solution exchange reaction (C= 1 Bo + H216o ~ C= 160 + 
H218Q). 
HO2C HO2C \ \ 
c==o c==:1ao 
I I 
HC HC 2 
\ SH 
2 
\ /SH p/ 
1aO1/ \ .....:::\ 01/ 
OH OH 
31 32 
a. [18Q]Thiophosphonpyruvate 31 P NMR Shift Standards 
Analysis of the mixture obtained from this reaction was performed by 
using the 31 P NMR method of Cohn and Hsu (1978) to distinguish 
between and quantitate the four possible products differing in their 1 Bo 
labelling patterns at phosphorus, i. e., thiophosphenolpyruvate containing : 
(1) zero 1 Bo atoms at phosphorus (27), (2) one 1 Bo at the C2-0-P bridge 
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position (28), (3) one 1 Bo at the nonbridge position of phosphorus (29) , , 
and (4) one 1 Bo at the bridge position and one 1 Bo at the nonbridge 
position of phosphorus (30). In order to assess the resolution of the NMR 
analysis and also test for competing solution 1 Bo exchange at the ketone 
carbonyl position of the C2 1 Bo-labelled reactant 26, 31 P NMR analyses 
were conducted on product mixtures obtained from separate PEP mutase 
catalyzed reactions of [C(2)-18Q]thiophosphonopyruvate (32) and [P= 1 Bo, 
(C2)-18Q]thiophosphonopyruvate (26) in H216O. In the time frame 
required to complete the phosphomutase reactions of 32 and 26 60% of 
the 1 Bo label at the C2 carbonyl was lost. This level of wash-out could be 
easily accounted for in the test experiment and thus posed no problem. 
Equally important was the finding that the 31 P NMR resonances of each 
product, viz (al1-16Q)thiophosphoenol pyruvate (27) and [C(2)-
18 Q]th i ophosphoeno lpyruvate (28) formed from 32, and 
[P= 18Q]thiophosphoenolpyruvate (29) and [P= 1 Bo, C(2)-
18Q]thiophosphoenolpyruvate (30) formed from 26, were well resolved 
(0.026 ppm upfield shift for 180 in the bridge position 28 and 0.046 ppm 
for 1 Bo in the nonbridge position 29 on the phosphorus. 
b. PEP Mutase Crossover Experiment 
The PEP mutase crossover reaction was carried out with an 
equimolar ratio of 52 µmol (all-16Q)thiophosphonopyruvate and 52 µmo I 
[P= 1BQ, C(2)-1BQ]thiophosphonopyruvate with 1 0 units of PEP mutase at 
25°C for 1 0 min. For a purely intramolecular reaction pathway, we 
expected (based on a 60% 1 Bo wash-out at the C2 carbonyl) that (all-
16Q)thiophosphoenolpyruvate (27), [C(2)-18Q]thiophosphoenolpyruvate 
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(28 ), (P= 1 Bo]thiophosphonopyruvate (29) and (P= 1 Bo, C2-
1 Bo]thiophosphonopyruvate (30) would be formed in a 1 : 0 : 0.6 : 0.4 ratio. 
For an intermolecular process, on the other hand, the 27 : 28 : 29 : 30 
ratio should be 1 : 0.25 : 1 : 0.25. 31 P NMR analysis of the product mixture 
(Figure 4) gives a 1 : 0 : 0.6 : 0.4 ratio of these substances, thus, 
demonstrating that the PEP mutase catalyzed rearrangement of 
phosphonopyruvate to phosphoenolpyruvate occurs via an intramolecular 
mechanism. 
Thus, we have demonstrated that PEP mutase rearranges a single 
substrate molecule to a single product molecule. However, there are 
numerous possible intramolecular mechanisms one can envision for the 
PEP mutase reaction, therefore, we needed to further define the 
intramolecular reaction mechanism. The next logical question to ask was 
how many steps are involved in this intramolecular rearrangement. At an 
elementary level, this process could occur in either a single, concerted step 
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Figure 4. The 31 P NMR spectrum of the mixture of isotopically 
labelled thiophosphoenolpyruvates obtained by PEP mutase catalyzed 
reaction of a mixture of [P= 1 Bo, C(2)-1 Bo]thiophosphonopyruvate (26) 
and [all-1 6Q]thiophosphonopyruvate (Scheme 2) . The observed 
resonances correspond to the thiophosphoenolpyruvate isotopomers 27, 
29, and 30 as labelled. 
7 1 
B. Is the PEP Mutase-Catalyzed lntramolecular 
Rearrangement Concerted or Stepwise? 
The enzyme catalyzed intramolecular rearrangement of 
phosphonopyruvate to PEP could occur in either a concerted or a stepwise 
fashion (Scheme 21 ). The experimental technique we employed to 
distinguish between these two possibilities was a phosphorus 
stereochemical analysis of the enzyme reaction. Although the results 
contained herein may be somewhat complicated the conclusion to which 
they point is unambiguous: PEP mutase catalyzes a stepwise 
rearrangement of P-pyr to PEP. 
1. Analysis of Possible Mechanisms 
Examples of the two general reaction types are shown in Scheme 
27. The single step process corresponds to a sigmatropic rearrangement 
and, as such, should proceed via a Mobius transition state75 (pathway A, 
Scheme 27). There are several possible stepwise mechanisms. By 
definition, the stepwise process must possess, between each step, a 
discrete intermediate. The form of this intermediate can be widely variable. 
The first of these (pathway B, Scheme 27) involves heterolytic dissociation 
of the phosphorus from the bridge oxygen to form a paired monomeric 
metaphosphate-enolate anion intermediate. Addition of the phosphorus of 
metaphosphate to the C3 of pyruvate enolate would then form 
phosphonopyruvate. The second possible nonconcerted mechanism 
(pathway C, Scheme 27) would proceed via formation of an 
oxaphosphetane intermediate, formed by bonding of the carbonyl oxygen 
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in the pyruvate moiety to the phosphonate phosphorus followed by rupture 
of the O-P bond. involves covalent participation by the enzyme through use 
of a nucleophilic active site amino acid residue to accept to the phosphoryl 
group from C2 of phosphonopyruvate and transfer it to the oxygen atom of 
the resulting pyruvate enolate. The third mechanism, described by Seidel 
et. al.91 in 1990 and shown as pathway D in Scheme 27, proceeds through 
strain free 5-membered transition states associated with transfer of the 
phosphoryl group from C2 to form an acylphosphate intermediate and with 
subsequent nucleophilic attack by the charged oxygen atom of the enolate 
moiety. A fourth (pathway E in Scheme 27) involves covalent participation 
by the enzyme through use of a nucleophilic active site amino acid residue 
to accept to the phosphoryl group from C2 of phosphonopyruvate and 























a. Precedence for a Concerted Mechanism 
Although no precedence for concerted phosphoryl shifts could be 
found in the literature, one example of a pericyclic process in an enzyme 
reaction has been found, namely chorismate mutase. The rearrangement 
of prephenate to chorismate shown in Scheme 28 is a Claison 
rearrangement. It has been suggested that chorismate mutase assists the 
rearrangement of chorismate to prephenate by holding the substrate in the 
correct alignment thereby allowing the sigmatropic shift to occur readily.92 
The concerted mechanism proposed for the PEP mutase is justified in light 
of the lack of information surrounding the mechanisms of enzyme-
catalyzed phosphoryl transfers involving phosphonates. 
Scheme 28. Chorismate Mutase Catalyzed Rearrangement of 
Chorismate to Prephenate 
chorismate prephenate 
b. Precedence for Stepwise Mechanisms 
Of the four stepwise mechanisms proposed only two have 
precedence in phosphoryl transfer enzymes. The most likely stepwise 
mechanism involves the formation of a phosphorylated enzyme 
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many examples of phosphoryl enzyme intermediates in the reactions 
catalyzed by phosphatases,93 phosphomutases,94 and adenosine 
triphosphatases.95 The other intermediate in the enzyme phosphoryl 
mechanism is the enolate of pyruvate, which is known to be stabilized in 
pyruvate kinase96 and pyruvate phosphate dikinase.97 Some enzymes 
which are believed to catalyze phosphoryl transfers in a dissociative 
fashion. Evidence supporting such dissociative mechanisms has been 
gained through 180 primary and secondary isotope studies. 
2. Stereochemical Analysis to Probe the Concerted 
vs Stepwise Mechanisms 
The second goal in our investigations of PEP phosphomutase 
catalysis was to determine whether the intramolecular rearrangement of 
phosphonopyruvate occurs by a concerted or stepwise pathway. We felt 
that this determination could be made by elucidation of the stereochemical 
course of the catalyzed reaction. The concerted reaction is expected to 
invert the phosphorus stereochemistry while any stepwise process should 
retain the phosphorus stereochemistry. 
a. Stereochemical Course of the Concerted 
Reaction 
Orbital topology considerations75 suggest that a concerted route 
(pathway A in Scheme 27) for suprafacial C to O 1, 3-phosphoryl migration 
should proceed through a Mobius transition state with inversion of 
configuration at phosphorus. This prediction is based on the analogy 
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gained from studies of 1,3 sigmatropic rearrangements of a carbon 
systems carried out by Berson.98 Scheme 30 illustrates the 
rearrangement of endo-bicycl[3.2.0]-hept-2-en-6-yl acetate (33) to exo-
norbornyl acetate (34) was shown to take place with inversion of 
configuration at the migrating carbon. 
Scheme 29. 1 ,3-Sigmatropic Carbon Shift Occurs with Inversion 







b. Stereochemical Course of the Stepwise Pathways 
All of the possible stepwise process should retain the original 
phosphorus stereochemistry. The four stepwise mechanisms are shown in 
Scheme 27. The metaphosphate formed in the dissociative pathway 
(pathway B, Scheme 27) should rebond to the pyruvate unit at C3 using 
the same face of the phosphorus from which the pyruvate unit dissociated. 
Thus, retention of stereochemistry at phosphorus is predicted. The double 
displacement pathway (pathway E, Scheme 27) should also display net 
retention of the phosphorus configuration owing to the fact that two 
sequential, in line displacements are involved and each should invert the 
configuration at phosphorus.74 
The mechanism involving the four-membered ring, oxaphosphetane 




phosphorus stereochemistry based upon information gained from studies 
of the Wittig reaction and other reactions which occur through analogus 
carba- and azaphoshetane intermediates. The prediction that this 
mechanism should retain the absolute configuration at phosphorus is 
based upon the assumption that the pentavalent phosphorus is formed by 
apical attack opposite the more electronegative sulfur or oxygens.99 
Pseudorotation is then required to place the leaving group in an apical 
position for departure. (Scheme 30) 
Scheme 30. Reactions Proceeding Through a Phosphetane 
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In the Wittig reaction oxaphosphetane intermediates analogous to 
35 and 36 (Nu = 0, Lg = C ) undergo pseudorotation at a rate 108 faster 
than the rate of decomposition.1 oo However, pseudorotation within the 4-
membered ring to place the leaving group in the apical position always 
leads to retention of configuration of the phsophorus atom. Corroborative 
evidence for retention of configuration via this mechanism can be found in 
the results of Stec101 and Gerlt.102 Stec showed that treatment of 
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phosphoroanilidate 37 with potassium and carbon disulfide produced the 
thiophosphate 38 with retention of configuration (Scheme 31 ). 
Scheme 31. Conversion of Phosphoranilidates to Thiophosphates 
Proceed with Retention of Configuration 
NHPh s 
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Gerlt demonstrated a similar conversion of phosphoroanilidate 37 with 
[180]2 carbon dioxide to form 39 to proceed with retention of configuration 
(Scheme 31 ). These reactions presumably go through an 
azaphosphetane intermediate which should be analogous to the possible 
oxaphosphetane intermediate in the PEP mutase reaction. 
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We anticipate that pathway D involving initial transfer of the 
phosphoryl grouping to the internal carboxyl group should also proceed 
with overall retention of configuration at phosphorus since it is comprised of 
two individual steps, each of which should preserve the original 
phosphorus configuration. Each step would require pseudorotation in a 
cyclic pentavalent phosphorus intermediate, as opposed to concerted back 
side displacement, since critical steric constraints are placed on the 
entering nucleophile and leaving group. 
3. Design of the Phosphorus Stereochemical 
Analysis 
In order to gain information about these mechanistic alternatives, 
the stereochemical course of the PEP phosphomutase rearrangement was 
explored. For this purpose, enantiomerically pure samples of the antipodes 
of a chiral phosphonopyruvate with known stereochemistry were needed 
as was a method of determining the absolute configuration of the chiral 
PEP product formed. One option was to use the enantiomers of chiral 
[1 Bo, 17 O, 16Q-P]phosphonopyruvate as stereochemical probes and to 
analyze the corresponding enantiomers of [1 Bo, 17 0, 1602-
P]phosphoenolpyruvate, the product of enzymatic rearrangement. Another 
involved the use of the enantiomers of [P= 1 Bo]thiophosphopyruvate as 
chiral probes and required the stereochemical analysis of the 
corresponding [P= 1 Bo]thiophosphoenolpyruvate enantiomers. We 
elected to use the latter approach based on an initial evaluation that the 
sulfur rather than the 17 0 replacement to create a chiral center at 
phosphorus would represent an easier synthetic challenge and at the 
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same time would take advantage of the published procedure 101 for the 
configurational analysis of the chiral product, 
[1 Bo,]thiophosphoenolpyruvate. 
a. Synthesis of Chiral Thiophosphonopyruvate 
The synthetic route to the individual enanteomers of chiral 
[18Q]thiophosphonopyruvate (31 a and 31 b) that was developed is oulined 
in Scheme 32. It involves the elaboration of methylphosphonothioic 
dichloride to the (Sp,Sc) and (Rp,Sc) diastereomers of the N, P-dimethyl-N-
( 1-phenylethyl)-0-[2-(trimethylsilylethyl] phosphonamidothioate (22a and 
22b ). Reaction of dichloride 19 with the lithuim amide of (S)-N-methyl-N-
(1-phenylethyl)amine to give a mixture of 22a and 22b. Separation of 
these diastereomers was accomplished by HPLC. In order to determine 
the configuration of the phosphorus atom in each of the diasterisomers, the 
crystalline p-nitrophenacyl derivative was prepared from 22a by removal of 
the trimethylsilylethyl protecting group by ~-elimination using cesium 
fluoride followed by S-alkylation. X-ray analysis 103 of 40 provided the 
structure shown in Figure 5 and the absolute stereochemistry at 
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Figure 5. X-Ray Structure of the Crystalline Derivative of 40 Derived 
from the Methylphosphonamidiate 22a. 
Conversion of the (Sp,Sc) and (Rp, Sc) diastereomers (22a and 
2 2 b) of N, P-Di methyl-N-( 1-phe nylethyl )-0-[2-(tri methylsi lyl)ethyl] 
phosphonamidothioate to the respective (Rp) and (Sp) enantiomers (31 a 
and 31 b) of [P= 1 BQ]thiophosphonopyruvate was accomplished by 
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present in the sample served as a chemical shift standard thus allowing 
determination of the magnitude of the 180 induced chemical shift of the ~-
P resonance. The 0.037 ppm isotopic shift observed (Figure 6) for the 
(Sp)-[18Q-P]ATP~S (41a) sample produced from the [P= 
1 8Q]thiophosphoenolpyruvate enantiomer 29a derived from (Rp)-
[P= 1 Bo]thiophosphonopyruvate 31 a demonstrates that the 1 Bo is located 
in a nonbridge position. Thus, [P= 1 Bo]thiophosphoenolpyruvate 29a 
generated in this way has the Rp configuration. The 0.021 ppm isotopic 
shift observed for the (Sp)-[18Q-P]ATP~S sample (41 b, Figure 7) 
produced from the [P= 1 Bo]thiophosphoenolpyruvate enantiomer 29b 
derived from (Sp)-[P= 18Q]thiophosphonopyruvate 41 b demonstrates that 
the 1 8 0 is located in the bridge position and, that this 
[P= 1 Bo]thiophosphoenolpyruvate precursor 29b has the Sp configuration. 
In summary, PEP phosphomutase catalyzes the conversion of (Rp)-[P= 
1 Bo]thiophosphonopyruvate to (Rp)-[P= 1 Bo]thiophosphoenolpyruvate and 
of (Sp)-[P= 1 8 O]thiophosphonopyruvate to (Sp)-
[P= 1 Bo]thiophosphoenolpyruvate (Scheme 33). Thus, we conclude that 
the PEP phosphomutase reaction proceeds with retention of configuration 
at phosphorus. 
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Scheme 33. Stereochemical Analysis of the Thiophosphonopyruvate to 
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4. Direct Evidence for Carboxyl-Assisted P-N Bond 
Hydrolysis with Retention of Phosphorus 
Stereochemistry. 
The stereochemical assignments of the 
[P= 1 Bo]thiophosphonopyruvate enantiomers 31 a and 31 b (Scheme 32) 
are based on two considerations: (1) the phosphorus stereochemistry of 
the (Sp,Sc)- and (Rp,Sc)-3[[methyl(1-phenylethyl)amino]phosphinothioyl]-
2-oxo-2-propanoate diastereomers 24a and 24b derived from the X-ray 
crystallographic determination of the phosphorus stereochemistry in the p-
nitrophenacyl derivative 40 of the (Sp,Sc)-N,P-dimethyl-N-(1-phenylethyl)-
O-[2-(trimethylsilyl)ethyl]phosphonamidothioate diastereomer 22a, and (2) 
the assumption that acid catalyzed hydrolyses of the diastereoisomers of 
the 3[[methyl(1-phenylethyl)amino]phosphinothioyl]-2-oxo-2-propanoate 
diastereomers 24a and 24b in H21 Bo take place with retention of the 
phosphorus configuration. Below, we provide evidence to support the 
proposal that hydrolyses of the thiophonamidate diastereomers do in fact 
follow this stereochemical course. 
a. Kinetic Evidence for Carboxyl-Assisted P-N Bond 
Hydrolysis 
Acid catalyzed hydrolyses of phosphoroamidates and 
phosphonamidates have been previously reported106,10? to occur with net 
inversion of phosphorus stereochemistry. Our original, 108 and since 
revised, 109 assumption was that hydrolyses of the diastereoisomers 24a 
and 24b would follow this same stereochemical course. Two features of 
the thiophosphonamidate hydrolysis reactions however, suggested to us 
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that these 3-[[methy/(1-phenylethyl)amino]phosphinothioyl]-2-oxo-2-
propanoate diastereomers were not behaving as "typical" 
thiophosphonamidates. For example, while the hydrolysis of the 
diastereoisomers of the close structural analog, N-(l-phenyleth-1 -y/)-[1 lo, 
1 Bo-PJ-1-ethoxylvinylthiophosphonamidate, studied earlier in our 
laboratory44 required 3.5 h at 25 °C in 1.0 M p-TsOH/THF-H2 16o for 
completion, hydrolyses of the related diastereomers of 24a and 24b were 
complete within 1 o sec under much less vigorous conditions (2 
equivalents of HCI in H21 Bo, 25° C). In addition, we44 have observed that 
hydrolysis of each of the diastereoisomers of N-(l-phenyleth-1-yl)-f 1
7O, 
1 Bo-PJ-1-ethoxylvinylthiophosphonamidate consistently gave ca. 60% 
inversion of configuration at phosphorus and ca. 40% racemization. In 
contrast, 24a and 24b were each found to undergo acid catalyzed 
hydrolysis in H21 Bo to produce single fP= 1 BoJthiophosphonopyruvate 
enantiomers. This was demonstrated by the formation in each case of a 
single (Sp)-[P(f3)= 1 BoJATPf3S product (Figure 7) via the reaction sequence 
displayed in Scheme 35. 
Both the larger than expected hydrolysis rates tor 24a and 24b and 
the atypically "clean" stereochemistry indicated that neighboring group 
assistance by the carboxyl substituent was likely occurring in these 
reactions (Scheme 34). In tact, precedence tor carboxyl group participation 
in hydrolysis reactions of this type can be found in the work of Schray and 
Benkovic. 110 These investigators have demonstrated that hydrolysis of the 
O-benzyl phosphate ester of phosphoenolpyruvate is assisted through 
initial intramolecular displacement of the alcohol leaving group by the 
89 
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internal carboxyl moiety (Scheme 36) followed by ring opening of the 
resulting phospholactone. 
Scheme 34. Carboxylate Participation in Thiophosphonamidate and o-
Benzyl Phosphate Ester Hydrolysis 
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b. Stereochemical Evidence for Carboxyl-Assisted P-N 
Bond Hydrolysis 
At the outset, it appeared that the most expedient way to introduce 
the 1 Bo-label by H21 Bo displacement of the amine functionality in the 3-
[[methyl(1-phenethyl)amino]phosphinothioyl)-2-oxo-2-propanoates without 
the assistance by the carboxyl group would be to subject the bis-
trimethylsilylethyl esters 23a and 23b (Scheme 32) to mild acid hydrolysis 
in H21 Bo and then to remove both the carboxylate and phosphonate 
silylethyl ester groups. However, this approach was not feasible owing to 
the fact that the product of the hydrolysis reaction, [[2-
(trimethylsilyl)ethoxy)phosphinothioyl)-2-oxo-2-(trimethylsilyl)ethyl 
propanoate, does not undergo desilylethylation at the thiophosphonate 
center when treated under the standard deblocking conditions (eg . 
CsF). 111 Likewise, classical ester C-O bond cleaving reagents like TMSBr 
and TMSI, which work well with phosphonate monoesters, 111 fail to 
deesterify thiophosphonate monoesters. The results clearly point out the 
necessity for 2-trimethylsilylethyl deprotection of the thiophosphonamidate 
prior to hydrolytic displacement of the amine moiety. To accomplish this, 
selective thiophosphonamidate monodesilylethylation of 23a by treatment 
with CsF was attempted. Indeed, the monoester 42a (Scheme 35) could 
be prepared in this way (contaminated with starting material and 
phosphinothioyl-2-oxo-2-[(trimethylsilyl)ethyl propanoate (43a) by treating 
23a with one equivalent of CsF. 
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Hydrolysis of 42a under mild conditions (viz 1.2 equivalents of p-
TsOH, 25°C, 20 min) led to the replacement of the amine substituent with 
OH as desired but also resulted in the hydrolysis of the (2 -
trimethylsilyl)ethyl carboxyester substituent. Given the mild reaction 
conditions employed, this secondary hydrolysis reaction was unexpected. 
Because the relative timing of the two hydrolysis events was unknown, the 
issue of carboxyl group participation in the hydrolysis at phosphorus 
remained. To resolve this problem we took steps to identify the cause of 
the abnormally rapid deesterification in 42a and to subsequently eliminate 
it. 
Consideration of alternatives to the classical addition-elimination 
mechanism for ester hydrolysis led us to consider solvolysis of 42a by 
nucleophilic attack at silicon. Consequently, the non-silyl analog, 3-
[[methyl( 1-phenylethyl)amino)[2-trimethylsilyl)ethoxy]phosphinothioyl]-2-
oxo-ethyl propanoate (44a) was prepared and then subjected to the same 
hydrolysis conditions used for 42a. The hydrolysis of 44a took place with 
the same efficiency as that of 42a ruling out the suspected reaction 
pathway. By the process of elimination, ester hydrolysis by neighboring 
group (viz. thiophosphono moiety) assistance was adopted as a working 
model for the deesterification reaction of 42a. As illustrated in Scheme 36, 
the participation of the thiophosphono moiety in the deesterification of the 
carboxy ester group in 42a could occur before the hydrolytic displacement 
of the N-metheyl-N-(phenethyl)amine from the phosphorus (pathway I) or, 
preferably, after it (pathway II). We reasoned that if deesterification 
occurred first, 42a would be converted to 24a and hence (in H2 1 Bo) to 
the same [P= 1 Bo]thiophosphonopyruvate enantiomer (31 a) generated by 
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the hydrolysis of 24a (Scheme 32). On the other hand, if hydrolysis at 
phosphorus in 42a preceded deesterification, the stereochemistry at 
phosphorus would be inverted and the [P= 1 Bo]thiophosphonate 
enantiomer (31 b) having the opposite configuration would be generated.4 
44a 
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To distinguish between the two pathways of Scheme 36, the 
configuration at phosphosphorus in the [P= 1 Bo]thiophosphonate product 
obtained from the hydrolysis of 42a in acidic H21 Bo was determined 
(relative to the [P= 1 Bo]thiophosphonate product from 24a) by using PEP 
phosphomutase to convert the [P= 1 Bo]thiophosphonopyruvate to 
[P= 1 BQ]thiophosphoenolpyruvate and the combined actions of pyruvate 
kinase and myoki nase (Scheme 33) to convert the 
[P= 1 BQ]thiophosphoenolpyruvate to 1 Bo-labelled ATPPS for analysis. 
Figure 7 shows that the [P= 1 Bo]thiophosphonopyruvate generated from 
42a consisted of a 87:13 mixture of the enantiomers 31 a and 31 b, 
respectively. For comparison, the hydrolysis of 24a had produced only 
enantiomer 31a. These results were interpreted to mean that both of the 
reaction pathways shown in Scheme 36 were operative in the hydrolysis of 
42a and that the pathway leading to 31 a by deesterification followed by 




30 . 00 
Figure 7. The P-P region of the 31 P NMR spectra of a mixture of (Sp)-
(all-16Q)ATPPS and (Sp)-[P(P)= 18Q]ATPPS (41a and 41b) isotopomers 
derived from (Sp)- and (Rp) -[P= 1 Bo]thiophosphoenolpyruvate 
enantiomers 29a and 29b formed via PEP mutase reaction of a mixture of 
(Sp )-and (Rp )-thiophosphonopyruvate enantiomers 31 a and 
31 b .produced from the hydrolysis of 42a. 
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Given this finding and our original goal which was to demonstrate 
that hydrolysis of 24a and 24b in acidic H21 So proceeds with carboxyl 
group assistance (and hence with retention of configuration), the focus of 
the final phase of this work became the design and synthesis of 
carboxyester derivatives of 24a and 24b which would hydrolyze to 
[P= 1 Bo]thiophosphonate enanitomers 31 b and 31 a, respectively by 
following pathway II of Scheme 36 and avoiding pathway I. The approach 
taken to reduce the rate of thiophosphonamidate assisted carboxylate 
ester cleavage relative to amine hydrolysis was to increase the steric bulk 
of the alkyl group at the carboxyl center by using an isopropyl protecting 
group in place of the 2-trimethylsilylethyl protecting group. The isopropyl 
derivatives 46a and 46b were thus prepared (Scheme 37) and 
independently subjected to hydrolysis in acidified H21 Bo. This led to 
removal of both N-methyl-N-phenylethylamine and isopropanol. 
Stereochemical analysis by the procedure described above revealed that 
near equal amounts of [P= 1 Bo]thiophosphonate enantiomers 31 a and 
31 b had formed in reaction of the individual isopropyl ester diastereomers, 
46a and 46b. Specifically, the thiophosphonamidate 46a having the (Sp) 
configuration at phosphorus gave rise to 55% of the same (Rp)-
[P= 1 Bo]thiophosphonate enantiomer (31a) which is formed exclusively by 
hydrolysis of the the "unblocked" (Sp,Sc)-3-
[[methyl(phenylethyl)amino]phosphinothioyl]-2-oxo-propanoate (24a) and 
45% of the enantiomer (31 b) with the opposite (Sp) configuration. 
Likewise, hydrolysis of the isopropyl (Rp,Sc)-thiophosphonamidate 46b 
produced 57% of (Sp) (3 1 b) and 43% (Rp)-
99 
[P= 1 Bo]thiophosphonopyruvate (31 a). The 31 P NMR result is shown in 
Figure 8. 
Scheme 37. Synthesis of the iso-propyl protetected carboxyl derivative. 
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Figure 8. The ~-P region of the 31 P NMR spectra of a mixture of (Sp)-
(all-16Q)ATP~S and (Sp)-[P(P)= 18Q]ATP~S (41a and 41 b) isotopomers 
derived from (Sp)- and (Rp)-[P= 1 Bo]thiophosphoenolpyruvate 
enantiomers 29a and 29b formed via PEP mutase reaction of a mixture of 
(Sp )-and (Rp )-thiophosphonopyruvate enantiomers 31 a and 
31 b.produced from the hydrolysis of 46a. 
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These results indicate that utilization of the isopropyl ester leads to 
retardation of the rate of carboxylate deesterification as compared to 
thiophosphonamidate hydrolysis thus resulting in near equal rates for the 
two pathways. In an attempt to obtain a more selective stereochemical 
result, hydrolysis of the Oc-tert-butyl derivative was explored. 
Unfortunately, as a result of the limited solubility of this substance in water, 
the acid catalyzed hydrolysis required the use of a mixed aqueous-organic 
solvent system. Under these conditions, dethiophosphonylation of the 
product, thiophosphonopyruvate, to form thiophosphate occurs rapidly. 
Thus, our conclusion regarding the neighboring group participation by the 
carboxyl group in the hydrolytic displacement of the N-methyl-N-
p hen y I et h y I amine from the (Sp,Sc)-3-
[[ methy l(phe nylethyl)ami no ]phosph i nothioyl]-2-oxo-propanoate (24a) 
rests upon the stereochemical trends observed in the enantiomeric 
compositions of the [P= 1 So]thiophosphonopyruvate products generated 
by hydrolysis of single diastereomers of (Sp,Sc)-and (Rp, Sc) 3-
[[methyl(phenylethyl)amino]phosphinothioyl]-2-oxo-propanoate (24a and 
24b ), and its Oc-2-trimethylsilylethyl (42a) and Oc-isopropyl analogs 
(45a and 45b). The combined results suggest that the configuration at 
phosphorus is retained in hydrolysis of the (Sp,Sc)-and (Rp,Sc)3-
[[methyl{phenylethyl)amino]phosphinothioyl]-2-oxo-propanoate 
diastereoisomers 24a and 24b as a result of the carboxyl group 
assistance depicted in Scheme 34. Furthermore, esterification of the 
assisting carboxyl group does not fully reverse this stereochemical 
outcome because hydrolysis of the carboxyl ester is competitive with 
displacement of the amine function (Scheme 36). However, the relatively 
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high level (ca. 50%) of inversion of phosphorus configuration observed for 
reaction of the isopropyl ester nicely correlates with an expected decrease 
in the rate of deesterification of this substance. 
We conclude that the stereochemistry of the hydrolysis of the key 
[ P = 1 8 O]thiophosphonate precursor , -3-
[[ methyl (phenylethyl)ami no ]phosphi nothioyl]-2-oxo-propanoate (24) in 
acidic H21 Bo, proceeds with retention of configuration and, therefore, that 
the PEP phosphomutase catalyzed rearrangement of this substance to [P= 
1 Bo]thiophosphoenolpyruvate also proceeds with retention of 
configuration. These conclusions are consistent with those recently made 
by Knowles and his coworkers in their follow-up91, 112 to our original 
communication 1 OB on the stereochemistry of the PEP phosphomutase 
reaction. 
The observed intramolecular nature and retention of phosphorus 
stereochemistry for the PEP phosphomutase catalyzed rearrangement of 
phosphonopyruvate to phosphoenolpyruvate has important mechanistic 
implications. Clearly, the two intermolecular pathways in which reaction 
occurs between either pyruvate and phosphonopyruvate or two molecules 
of phosphonopyruvate can be eliminated from consideration on the basis 
of 1 Bo-labelling results (Figure 4) which show that phosphoryl group 
transfer occurs between carbon and oxygen of the same substrate 
molecule. Also, our stereochemical findings preclude the operation of a 
concerted, pericyclic mechanism since inversion of the phosphorus 
configuration is predicted for this process on the basis of orbital topology 
control. This leaves the four nonconcerted mechanisms (B through E in 
Scheme 27) as being possible for the PEP phosphomutase reaction. 
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Finally, the similar reactivity of the oxo- and thio-substituted substrates 
suggests that, independent of mechanism, nucleophilic attack at the 
phosphorus is not involved in the rate limiting step for this rearrangement 
reaction .113 
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C. The Search for the Intermediate in the PEP¢:> P-pyr 
Rearrangement. 
Since the stereochemical course of the PEP mutase reaction 
involves retention of the phosphorus configuration a stepwise mechanism 
is operative. The stepwise mechanism can be identified by its 
intermediate. The intermediates in the four stepwise mechanisms are 
shown in Scheme 28. We sought to determine which stepwise mechanism 
was operative by attempting to trap an intermediate by performing rapid-
quench experiments with radiolabeled phosphonopyruvate. 
The most likely intermediate most susceptible to trapping is the 
pyruvate which is formed in the phosphorylated-enzyme mechanism 
(Pathway E in Scheme 28). The enolate of pyruvate is formed in the 
dissociative mechanism but is expected to be too short lived to be trapped. 
[3H]P-pyr was used as a radiolabeled probe to monitor the disappearance 
of P-pyr, the transient formation of pyruvate and PEP formation in single 
turnover reactions. The turnover number for PEP mutase is 30 s-1, and 
hence a single turnover in the active site should require 33 msec if product 
release is not rate limiting. In theory we should be able to see an 
intermediate using the KinTek rapid quench instrument since it can 
produce reaction times as short as 5 msec. Radiolabeled PEP would 
appear to be a more obvious choice as a probe since it is commercially 
available. However the equilibrium of PEP¢::>P-pyr is > 500:1. Although 
the Km of PEP is not known, we anticipated that it would be difficult to 
accumulate enzyme-bound species in the thermodynamically unfavored 
PEP⇒P-pyr direction. 
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An idealized time course for the reaction of P-pyr to PEP via a single 
intermediate is shown in Figure 9. 
100 
PE P 
pyruva t e 
P-pyr 
0 
50 100 150 
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Figure 9. Idealized hypothetical time course of the PEP mutase reaction 
with [3H]P-pyr under single turnover conditions. 
Our ability to trap the intermediate in rapid quench experiments 
would depend on its lifetime. As can be seen in Figure 10 the intermediate 
can be trapped only if the rate of breakdown of the intermediate, ks is slow 
with respect to its rate of formation, kJ. The following pages describe the 
rapid quench experiments we performed to test the intermediacy of 
pyruvate in the PEP mutase reaction. 
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K1 K3 Ks K7 
E + PYR ~ E-P-pyr ~ E-1 ~ E-PEP ~ E + PEP 
K2 K4 K6 Ks 
Figure 10. Kinetic equation of the PEP mutase-catalyzed rearrangement 
of P-pyr 
1. Rapid Quench Experiments with PEP Mutase Reaction 
The experimental design is illustrated in Figure 11 . Forty-three 
micro liters of 1 0 µM [3H]P-pyr and 43 µL of 100 µM PEP mutase were 
mixed in a rapid quench apparatus and quenched with 164 µL of 20 mM 
HEPES adjusted to pH 1.6 with HCI, at varying conversions (5 to 1000 ms). 
The reaction products, [3H]P-pyr and [3H]pyruvate were reduced with 
NaCNBH3 in order to prevent the loss of the tritium by solvent exchange. 
After 15 min the pH of reaction solution was adjusted to 7. The reaction 
mixture was subjected to chromatographic separation by using an HPLC 
equipped with an anion exchange column. A mixture of 0.1 M KH2PO4 
and 0.4 M KCI (pH 2.75) was used as eluent. 3H2O and [3H]lactate eluted 
at the solvent front and [3H]P-lactate at 4 min and [3H]PEP at 12 min. A 
separate chromatography using a mixture of 3 mM KH2PO4 and 10 mM 
KCI (pH 5.5) as eluent was employed to resolve [3H]lactate (10 min) from 
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Figure 11. Flowchart of the rapid quench experiments. 
Control studies were carried out to test the efficient of NaCNBH3 
reduction of P-pyr to P-lac, pyruvate to lactate and to determine whether of 
not lactate is not formed from either P-pyr or PEP under the quench or 
reduction conditions . Phosphonopyruvate (75 mM) and 
phosphoenolpyruvate (75 mM) were reacted separately with 75 mM 
NaCNBH3 at 25°C for 15 min at pH 2. 31 P NMR analysis indicated P-pyr 
(8=1 O ppm) was quantitatively converted to phosphonolactate (8=19 ppm) 
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with no observed phosphate (lactate) formation. The 31 P-NMR analysis of 
PEP/ NaCNBH3 reaction indicated the formation of 3% phosphate and 
hence 3% lactate. The 3% lactate formation was confirmed by 1 H NMR 
analysis of the same sample. A reaction containing pyruvate (75 mM) and 
NaCNBH3 (75 mM) quantitatively produced lactate as judged by 1H NMR 
analysis. The quantitative conversions of P-pyr to P-lac, pyruvate to lactate 
and the minimal formation of lactate from either P-pyr or PEP under these 
quench and reduction conditions allowed for the use of this methodology 
in the rapid quench analysis. 
a. Synthesis of [3H] P-pyr 
The phosphonopyruvate was labeled with tritium by exchange of the 
C-2 protons in 11 0 Ci/mol [3H]water at 25°C at pH 9 (the pH of a solution of 
Li3P-pyr) . After 24 h the [3H]P-pyr was precipitated with ethanol and dried 
in vacuo, thus producing [3H]P-pyr with a specific activity of 40 Ci/mol. A 
10 µM solution of [3H]P-pyr in 50 mM K+HEPES (pH 7.5) was prepared 
immediately before use in the rapid quench experiments. 
Because of the tendency of the tritium to exchange from the [3H]P-
pyr to solvent the purity of the synthetic [3H]P-pyr could not be determined 
by chromatographic separation of the [3H]P-pyr. Instead the purity of the 
[3H]P-pyr was examined by converting it to [3H]PEP by reaction with a 
catalytic amount of PEP mutase and in a separate experiment, by 
converting it to [3H]P-lac by reduction with NaCNBH3. Elution profiles 
obtained from HPLC anion exchange chromatographic analysis of the 
[3H]PEP derived from the [3H]P-pyr is shown in Figure 12 as is the elution 
profile obtained from the HPLC analysis of [3H]P-lac derived by reduction 
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of the [3H]P-pyr. These results indicate the synthetic [3H]P-pyr is a mixture 
of 14% 3H20, 8% of an unidentified contaminant, 78% [3H]P-pyr. 
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Figure 12. HPLC elution profiles of a) [3H]P-lac derived from a reaction 
of [3H]P-pyr and b) [3H]PEP derived from a reaction of [3H]P-pyr with a 
catalytic amount of PEP mutase 
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b. Single Turnover Experiment with [3H]P-pyr and Mg2+ 
Activated PEP Mutase 
An initial eperiment was carried to determine whether the rapid 
quench experiments could accurately measure the formation of PEP, the 
disappearance of P-pyr and detect a pyruvate intermediate by observing 
lactate formation . The concentration of each reactant in this initial 
experiment after mixing was [3H]P-pyr (ca. 13 µM), PEP mutase (46 µM) 
and MgCl2 (5 mM). The timecourse of the single turnover is shown in 
figure 13. 
The results in figure 13 indicated that we could follow the formation 
of PEP and the disapperance of P-pyr. Approximately 1 % of the P-pyr 
substrate was converted to lactate which corresponded to only 100 cpm, 
hence the measurement was very innacurate. Because the P-pyr 
concentration was not accurately quantitated the reaction may have been 
more than one turnover of PEP mutase. The next experiment was was 
perfomed to tighten up the conditions so as to obtain an acurate 
measruemt of the time required for a single turnover. 
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Figure 13. Time course for a single turnover of P-pyr in the active site of 
Mg 2+-activated PEP mutase at 25°C. The reaction contained ca. 13 µM 
[3H]P-pyr, 46 µM PEP mutase (subunit Mal. Wt. 39000 Daltons) , 5 mM 
MgCl2 and 50 mM K+HEPES (pH 7.5): (_., PEP, (e-) P-Lac, (o) lactate. 
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The single turnover experiment to determine the time required for a 
single turnover of PEP mutase was carried out using a buffered solution 
(43 µL) containing 100 µM PEP mutase, 10 mM MgCl2 which was mixed 
using the rapid quench instrument with a buffered solution (43 µI) 
containing 10 µM [3H]P-pyr to give final concentrations after mixing of PEP 
mutase (40-50 µM, Mol. Wt. 39,000), MgCl2 (5 mM), [3H]P-pyr (5 µM). After 
a specified time (5-200 msec) the solutions was quenched with 164 µL of 
20mM HEPES adjusted to pH 1.6 with HCI and reacted with NaCNBH3 
(final concentration 4 mM) . After 15 min the reaction mixtures were 
neutralized with 12 µL of 1 M KOH. The reaction products were then 
separated on HPLC. The results from this experiment are shown in Figure 
14. The single turnover was complete in about 20 msec. There was no 
evidence of a lag in the formation of PEP. No attempt was made to detect 
lactate. 
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Figure 14. Time course for a single turnover of P-pyr in the active site of 
Mg2+-activated PEP mutase at 25°C. The reaction contained 5 µM [3H]P-
pyr, 50 µM PEP mutase (subunit Mol. Wt. 39000 Daltons), 5 mM MgCl2 and 
50 mM K+HEPES (pH 7.5): ( .. ) PEP, (1'J) P-Lac. 
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These results indicated that the rate of turnover at 2soc is too fast to 
observe formation and reaction of a intermediate along the reaction 
pathway. Therefore, we attempted to change the reaction conditions (pH, 
metal cofactor, temperature) so that the turnover rate might be slow 
enough to evaluate intermediate formation during the initial phases of the 
reaction. From Vm pH profile, which is flat in the pH 6-9 range, we 
suspected that adjusting the reaction pH would have little impact on the 
turnover rate. The metal cofactor was found to have a small influence the 
rate of catalysis.4 The Vm of the PEP mutase reaction with other divalent 
metals replacing magnesium were Co2+ (0.5), Zn2+(0.4), and Mn2+(0.3), 
relative to the Vm for Mg2+. Although the reduction in Vm for these metals 
are somewhat small, the effect may be masked by a rate limiting product 
release step. The results in figure 14 indicate that product release may 
indeed be rate limiting, since the single turnover reaction was complete in 
1 5 msec which was less than the 33 msec predicted, based upon the 
turnover number of 30 s-1 obtained from initial velocity studies. In the hope 
that the reduced of Vm with these metals could result in the observation of 
an intermediate in a single turnover, we pursued a rapid quench 
experiment in which the magnesium cofactor was replaced with 
manganese. We chose to use manganese since it produced the largest 
reduction in Vm. 
2. Single Turnover Experiment with [3H]P-pyr and Mn2+. 
Activated PEP Mutase 
PEP mutase (0.3mg/ml,20 ml) was dialyzed against 50 mM 
K+HEPES(pH 7.5) containing 1 mM EDTA. The enzyme was then 
1 1 5 
reconstituted with 5 mM manganese chloride and concentrated to 50 µM 
The time course of a single turnover of the Mn2+-activated PEP mutase is 
shown in Figure 15. Equilibration of PEP and P-pyr in the active site took 
only 40 to 50 ms. Pyruvate was formed in about a 17% yield. This large 
amount of pyruvate may be due to either an Mn2+-catalyzed solution 
hydrolysis of [3H]P-pyr or by a manganese-induced enhancement of a 
dephosphorylase side reaction catalyzed by PEP mutase. The time course 
showed that pyruvate formation did not precede PEP formation, therefore 
these data do not implicate pyruvate as an intermediate. 
The rate of transformation of P-pyr could not be followed in this time 
course. The P-pyr precipitated during the quench and could be found 
associated with the enzyme pellet. Presumably the unreacted P-pyr 
formed a complex with the manganese cofactor at low pH which was not 
soluble. This complication and the large amounts of pyruvate formed in 
this Mn2+-activated PEP mutase reaction discouraged us from further 
pursuing the use of manganese under other condition, such as altered pH 
or at a lower temperature. Thus having failed to significantly slow the PEP 
mutase reaction and trap pyruvate by using the manganese cofactor we 
opted to try reducing the temperature of the Mg2+-activated PEP mutase 
single turnover reaction. 
1 1 6 
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Figure 15. Time course for a single turnover of P-pyr in the active site of 
Mn2+-activated PEP mutase at 25°C. The reaction contained 5 µM [3H]P-
pyr, 50 µM PEP mutase (subunit Mal. Wt. 39000 Daltons) , 5 mM MgCl2 
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using the thiophosphonopyruvate as a substrate. However a method
ology 
for either labeling the thiophosphonopyruvate or 
the 
thiophosphoenolpyruvate product and pyruvate intermediate would 
need 





















0 20 40 60 80 100 
120 
Time, msec 
Figure 16. Time course for a single turnover of P-pyr in the active site o
f 
Mg2+-activated PEP mutase at 4°C. The reaction contained 5 µM [3H]P
-
pyr, 50 µM PEP mutase (subunit Mol. Wt. 39000 Daltons), 5 mM M
gCl2 
and 50 mM K+HEPES (pH 7.5): (e) PEP. Lactate (•) was obtained 
from 
separate reaction containing 5 µM P-pyr, 50 µM PEP mutase, 5 mM M
gCl2 




4. Determination of the Internal Equilibrium of PEP and 
P-pyr Bound to PEP Mutase 
In order to measure the equilibrium of the substrates bound in the 
active site of PEP mutase a high concentration of pure PEP mutase relative 
to radiolabeled substrate was used and the ratio of enzyme bound P-pyr to 
PEP at equilibrium was measured. A control reaction containing 43 µM of 
100 µM PEP mutase and 43 µM of 10 µM [3H]P-pyr was mixed in a rapid 
quench apparatus for 50 msec and quenched with 164 µI HEPES adjusted 
to pH 1.6 with HCI. The [3H]P-pyr in the quenched reaction was reduced 
with 4 mM NaCNBH3 for 15 min and then the solution was neutralized by 
the addition of 12 µL of 1 M KOH. The HPLC-separated products were 
quantified by scintillation counting. The reaction produced [3H]PEP (40%}, 
[3H]P-lactate (0%}, 3H20 (28%), and [3H]lactate (18%). The remaining 
14% of the radioactivity derived from the unidentified contaminant in the 
[3H]P-pyr starting material. The control experiments carried out to test P-
pyr and PEP hydrolysis under the quench conditions indicated that the 
[3H]lactate could in part (ca. 3-5%) be due to dephosphorylation of 
[3H]PEP during the quench and reduction reaction. The remaining (10%) 
of the pyruvate generated must be attributed to a minor dephosphorylase 
activity of the PEP mutase. This side reaction is not observed when the 
reaction is run with only a catalytic amount of PEP mutase. To circumvent 
this difficulty we decided to run a series of reactions for a fixed length of 
time and vary the PEP mutase concentration. We hoped we could find an 
ideal ratio of enzyme to substrate which minimized the dephosphorylase 
side activity, yet provide for maximum binding of the reactants to the 
enzyme. 
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Solutions of purified PEP mutase ranging from 2 to 200 µM in 50 
mM K+HEPES, 1 O mM MgCl2, pH 7.5 were prepared. Forty-three 
microliters each of PEP mutase and 10 µM [3HJP-pyr in 50 mM K+HEPES 
(pH 7.5) were mixed in a rapid quench apparatus at 25°C for 50 ms, and 
worked up with NaCNBH3 as previously described. Three control 
reactions containing a catalytic amount of PEP mutase and 10 µM [3H]P-
pyr, were run at 25°C for 5 min and worked up as previously described. 
These controls should reflect the enzyme reaction in the absence of the 
dephosphorylase side activity. The control reaction product mixture 
consisted of PEP (60%), P-pyr (0%), 3H2O (30%), and [3H]lactate (0% to 
3%). One control was run at the beginning of the experiment and two at 
the end of of the experiment. About 5% loss of label due to exchange with 
solvent occurred in between the time of the first and third control. The 
[3HJPEP, [3HJP-Pyr, and 3H2o were separated using an HPLC equipped 
with an anion exchange column as previously described (0.1 M KH2PO4, 
0.4 M KCI, pH 2.75). [3H]lactate coelutes with 3H 2O under these HPLC 
conditions. The amount of [3H]lactate in the product was calculated by 
subtracting the amount of 3H2o measured in the control reactions. The 
results are shown in Table 3 and a plot of [3H]PEP, [3H]P-Pyr, and 3H20 
(and [3H]lactate) formed vs P-pyr to PEP mutase ratio is shown in Figure 
17. The optimal ratio of PEP mutase active sites to [3H]P-pyr was 2:1. At 
this ratio of enzyme to substrate the ratio of [3H]PEP to [3H]P-pyr is about 
25:1. 
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Table 3: Amount of radioactivity associated with each product formed in 
the experiment determining the on-enzyme equilibrium of PEP mutase 
Amounts of Products cpm(% of total) 
Ratio [3H]H2O & [3H]P-lac [3H]PEP Total 
Enz/P-pyr [3H]lactate 
Control 1 1659(27.4) 3674(60.7) 6044 
20 2753(51.9) 1710(32.2) 5306 
10 2554(46.0) 2257(40 .1) 5557 
4 2136(37.9) 2744(48.7) 5640 
2 1785(32.6) 116(2.1) 2958(54.1) 5471 
1 1703(31.0) 776(14.1) 2307(42.0) 5493 
0 .2 1462(31.5) 1835(15.6) 621(13.4) 4645 
Control 2 2061 (30.8) 3886(58.2) 6681 
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Figure 17. Plot of % substrates and products vs PEP mutase (sub
unit 
Malec Wt. 39000 daltons) concentration of 86 µL reactions consisting 
of 5 
µM [
3H]P-pyr 5 mM MgCl2 in 50 mM K+HEPES buffer (pH 7.5) at 25°C, for 
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The occurrence of PEP mutase in both eukaryotic, T. pyriformis and 
prokaryotic, S. hygroscopicus, organisms suggests that it is the entry point 
into the phosphonate class of natural products. However, PEP mutase is 
not the only P-C bond forming enzyme. The other P-C bond forming 
enzyme, found in the bialaphos pathway, carboxyphosphinoenolpyruvate 
mutase, was recently discovered by Seto. Additionally, the P-C bond in 
fosfomysin is formed by an enzyme which is probably somewhat different 
than PEP mutase. The full spectrum of P-C bond forming enzymes has yet 
to be determined, but the two phosphonosynthases which are known are 
similar in that the rearrangement in the P-C bond formation direction 
appears to depend on decarboxylation. 
Bialaphos contains a C-P-C moiety. The first P-C bond comes from 
the PEP mutase rearrangement of PEP to P-pyr. The second P-C bond is 
formed by the enzyme carboxyphosphonoenolpyruvate (CPEP) mutase. 
CPEP mutase has been purified and has a specific activity of 217 U/mg. 
CPEP mutase is a homodimer with subunit molecular masses of 32,000. 
Although no mechanistic studies have been published on CPEP 
phosphonomutase its equilibrium apparently favors P-C bond formation, 
due to the thermodynamically favored decarboxylation. 
Since PEP mutase was found in both eukaryotic and prokaryotic 
organisms Seto and coworkers also expected to find PEP mutase activity in 
fosfomycin biosynthetic pathway. It was known from fosfomycin pathway 
studies that there must be an enzyme activity that forms a P-C bond from 
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PEP and that produces P-ald. However, contrary to their expectations, PEP 
mutase activity could not be found in Fosfomycin-producing strains of 
streptomyces. Even the very high fosfomycin-producing organism, S. 
wedmorensis 209-97 did not show PEP mutase (P-pyr conversion to PEP) 
activity. Lack of observable P-pyr⇒PEP activity in fosfomysin -producing 
bacteria may be rationalized if P-ald, and not P-Pyr, is the product of the P-
C bond forming enzyme. Such a transformation could be catalyzed by an 
enzyme or enzyme complex which couples P-C bond formation with loss of 
CO2. Thus, another class of P-C bond forming enzymes may have evolved 
which combine P-C formation with decarboxylation. 
In every known P-C forming pathway, the formation of a P-C bond 
seems to be always coupled to a subsequent decarboxylation. We have 
already suggested that the exergonic decarboxylation of P-pyr is what pulls 
the thermodynamic disfavored PEP⇒P-pyr rearrangement forward in the 
AEP biosynthetic pathway. Perhaps the phosphonosynthase in the 
fosfomycin pathway is a hybrid enzyme, similar to PEP mutase in that it 
forms the P-C bond from a rearrangement of PEP and similar to CPEP 
mutase in that the P-C bond formation is directly linked to decarboxylation. 
The detailed mechanism of PEP mutase catalysis is still not known 
We do know that PEP mutase catalyzes an intramolecular, stepwise 
rearrangement of P-pyr to PEP. The intermediate involved in that process 
remains to be identified. From the studies contained in this dissertation, 
one may speculate on the identity of the intermediate. Much of the data 
suggests the intermediate in the PEP(=> P-pyr most likely resembles 
metaphosphate. Metaphosphate is a short-lived species. Its lifetime is 
enhanced if the phosphoryl group is substituted with a sulfur atom 
127 
(metathiophosphate) . The rapid quench data indicate the intermediate 
involved in the PEP mutase reaction is very short-lived. Recall that 
thiophosphonopyruvate has a Vm which is on 80% that of the natural 
substrate. Usually thiophosphoryl analogs react with Vm on the order of 
100- to 1000-fold slower than their phosphoryl counterparts . Addition 
support for the Metaphosphate intermediate is contained in a resent study 
by Freeman et. a1.114 which characterized the solution hydrolysis of 
phosphonopyruvate at pH 7.5. The mechanism was determined to be 
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period to the stirred reaction mixture, and a white precipitate gradually 
formed. After six hours of stirring at ooc, so2 was bubbled through the 
mixture until the precipitate dissolved. The solvent and phosphorylchloride 
were removed in vacuo. and the SOCl2 that still remained was removed in 
vacuo by repeated evaporation with benzene. THF (300 ml) and cold 
H2O (6 ml} were added to the reaction flask . The THF was removed by 
rotary evaporation yeilding a brown oil. Water (250 ml) was added to the 
crude product and the solution was adjusted to pH 9.0 with UOH solution. 
The resulting LiPO4 precipitate was removed by centrifugation and 
acetone (500 ml) was added to the supernatant top precipitate P-Ald .. The 
resulting precipitate was centrifuged, resuspended in water, and loaded 
onto a 1.5 x 100 cm Dowex-1 (Ci-) column. The column was eluted with a 
one liter linear gradient of UCI (0.1 - 0.4M) in N-ethylmorpholine (5mM, pH 
7.5). P-ald containing fractions were identified by measuring the change in 
absorbance at 253 nm of a 1 ml solution containing a 10 µl a1 iquot of the 
fraction , 1 % (w/v) semicarbazide-HCI and 2% (w/v) sodium 
acetate.Fractions containing P-ald were pooled and concentrated in 
vacuo. 31 P NMR (D2O,pH 8.0) 9.3 ppm (t, J = 19.9 Hz). 
Phosphonoalanine (P-ala) Phosphonoacetaldehyde was 
prepared by the procedure described by Chambers and lsbell. 117 
Acetamide (14.68 g, 250 mmol) was added to dry benzene (350 ml) 
containing pyruvic acid (13.2 g, 150 mmol). The mixture was refluxed 
under an atmosphere of argon. The benzene/water azeotrope was 
removed via a Dean-Stark trap. After cooling the reaction mixture to 25°C, 
trimethylphosphite (66 ml) and dimethylphosphite (59 ml) were added to 
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the mixture. The reaction mixture was refluxed for 3 hours, cooled to 25°c 
and then stirred for 12 hours. Excess phosphite and volatile compounds 
were removed by short path distilation (130°C, 0. 7mm). The mixture was 
cooled to room temperature and concentrated HCI (250 ml) was added to 
the dark residue. The solution was refluxed for 48 hours. HCL was then 
removed by short path distillation. The residue was dissolved in a minima/ 
amount of H2o and decolorized with activated carbon (2 glmL) at 100 °c. 
The product was eluted on a 2.5 x 90 cm Dowex-50 (H+) column with 
deionized water. An aliquot from each fraction was spotted on a silica gel 
TLC plate. P-ala containing fractions were identified by visualization of the 
amine with ninhydrin spray. Fractions containing P-a/a were pooled and 
concentrated in vacuo. The P-ala was then purified by recrystalization 
from cold water. 31 p NMR.(D2O, pH 8.0) 19.0 ppm (dd, 26.0, 27.3 Hz). 
Phosphonopyruvate (P-pyr). Phosphonopyruvate was 
synthesized following the procedure of Anderson, et al 115- P-ala (0.5 g, 3 
mmol ) was added , to 50 ml of freshly dried methanol containing 0. 1 M 
HCI, under an atmosphere of argon. The reaction mixture was stirred for 
40 hours at 40 oc. N-ethylmorpholine was added to the reaction mixture 
until a pH of 7.0 was acheived. 3,5-Ditertiarybutylbenzoquinone (0.65 g, 3 
mmol) dissolved in 25 ml of dry methanol was added to the solution and 
stirred at room temperature for 4 hr. Fifteen ml of water were added to the 
reaction mixture and the pH of the solution was then adjusted to 4.0 with 
glacial acetic acid. After 12 hours, the reaction mixture was extracted with 
an equal volume of chloroform. The chloroform layer was washed with 3 
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hydrate (1 mM), phenylmethylsulfonylfluoride (50 mM), and trypsin inhibtor 
(50 mg/ml) at a pH of 9.4. For studies involving the elucidation of the 
biosynthetic pathway, cells were lysed in a tissue homogenizer fitted with a 
teflon pestel. For PEP phosphomutase purification and characterization 
studies, the cells were lysed using a French Presure Cell Press operated 
at 9000 psi . 
Reactions with Tetrahymena pyriformis Homogenate and 
Homogenate Fractions. Reactions consisted of 20 ml of a basal 
solution containing HEPES (50 mM), BSA (0.4%), MgCl2 (10 mM), l-
alanine (20 mM), pyridoxal phosphate and except where noted, thiamine 
pyrophosphate (2.5 mM) at pH 7.6 and 20 ml of cellular homogenate. 
Reactions were carried out at 27 oc on a gyratory shaker for ca. 12 h. 
Reactions were terminated by the addition of 40 ml trichloroacetic acid 
(20% w/v) and were subsequently centrifuged at 3000 g X 1 0 min. The 
resulting precipitant was twice washed with 40 ml trichloroacetic acid 
solution (5% w/v) and centrifuged at 3000 g X 1 0 minutes. The 
trichloroacetic acid solutions were the extracted three times with equivalent 
volumes of ethyl ether. To the ether was added one equivalent volume of 
absolute ethanol, and the mixture was centrifuged at 17,000 g X 10 
minutes. The ether was then evaperated in vacuo and loaded on a 
Dowex-50 (H+) column (2.5 X 30 cm). The column was eluted with 300 ml 
of water and then with 300 ml 3M NH4OH. The water fraction was dried in 
vacuo and rehydrated with D2O and analyzed for neutral or negatively 
charged phosphates and phosphonates by 31 P-NMR. The NH4OH fracton 
was concentrated to dryness and the residue rehydrated with a small 
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amount of water and loaded onto a Dowex-1 (CH3CQQ-) column (18 X 40 
cm). The column was eluted with 200 ml of water and then 250 ml acetic 
acid. The acetic acid fraction was concentrated to dryness and rehydrated 
with D2O and analyzed by 31 P NMR techniques. 
PEP Mutase Assay and Isolation. PEP mutase was assayed 
by following the formation of PEP from P-pyr. An ADP-pyruvate 
kinase/NADH-lactate dehydrogenase coupled assay for PEP resulted in a 
decrease in absorbance at 340 nm. The assay solution contained HEPES 
(50 mM), MgCl2 (5 mM), ADP (5 mM), NADH (0.25 mM), LOH (80 
units/ml) , pyruvate kinase (20 units/ml) , and P-pyr (1 mM). at pH 7.8, 
25°C The enzyme was purified by the method described by Bowman with 
minor modifications.4 Six grams of crude protein pellet was dissolved in 
50 mM triethanolamine (ph 7.5), 5, mM MgCl2, and 0.5 mM EDTA, 1, 10-
phenanthroline (1 mM), benzamidine hydrochloride hydrate (1 mM), 
phenylmethylsulfonylfluoride (50 mM), and trypsin inhibtor (50 mg/ml). 
and dialyzed for 9 hat 4°C against 2 L of buffer, which was replaced with 
fresh buffer every fifth hour. The remaining purification steps were carried 
out at 4°C. The dialyzed protein was loaded onto a 22 cm x 3.5 cm DEAE-
cellulose column (Sigma Chemical Co.) that had been equilibrated with 50 
mM triethanolamine (pH7.5) containing 5 mM MgCl2 and 0.4 mM OTT. 
lsocratic elution of the PEP mutase from the column was carried out with 
the equilibration buffer. 
The PEP mutase active fractions obtained from the DEAE-cellulose 
chromatography were made 25% (w/v) in ammonium sulfate and then 





rated · (W/v) am 
. wit






lf t eluted . 
a e, 5 mM 
MgCl2 and 
0.5 mM on. The
 column wa
s 






f 25% to 0%
 ammonium





 7.5), 5 mM
 MgCl2, an
d 0.5 mM on. 
The PEP 




















d onto a 10












 (pH 7.5) c
ontaining 5
 mM, MgClz



















° s P h o n o p y r u "a
te a n d
 R
 a c e m I c 




 To 80 mg
 (140 µmo








 :1 248 and 
24b) 
ere add 
ed 600 µI 
(30 mmol) 
of either 1







 of 12 N 
HCI. Atte
r 10 sec a
t 25 oc, 4
00 µI of 
Hepes (20 











ed to 8 w























J = 18.2 H
z) and 16
% [P= 1 so 21





· ppm, J 












ate (I, + 10.5




















































ured at pH 



























 (1 mM), M
gC/2 (5 mM









30 U) in K
+Hepes bu
ffer (50 mM
, pH 8). Th
e Km = 5 µ
M 













Km = 20 µ
M and Vm
 = 24 s-


















































































) (118 µ/) 
disso/ved . in 250 µ/ o
f H21 Bo (9
8%) was ad
ded to 7.5 m
l of 20 mM 










ted for 1 O min
 at 25° C 




















K+1; epes (pH 8) 
and 0.2 M E
DTA. The 31 
P NMR spec
trum of the m
ixture 














7> (60%) at +
39.443 ppm
 and for cc2-1 BQ]thiop
hosphoenolp
yruvate 



















. I 39 
, ions as de
scribed abov
e showed a 
phosphorus 
s,gna at + 
.397 




%) and at +3
9.368 ppm 






















 of 59 µmo/ 
each of 
fhiophosph 









c for 10 min w
ith 1 o units of PE
P phosphom
utase in 
S rnt of 20 
B) ntaining
 2.s mM Mg
C/2 . The re
action 
mM K+Hepe
s (pH co 
138 
mixture was subjected to the work-up procedure described above. The 
mixture obtained was analyzed by 31 P NMR giving the spectrum displayed 
in Figure 5. 
0 p-(2-Trimethylsilylethyl) 
Methylphosphonochloridothioate (20). To a stirred solution of 2-
trimethylsilylethanol (9.78 g, 82.7 mmol) in THF (150 ml) was added, 
dropwise, n-butyllithium (1.2 M, 75.2 ml, 90.2 mmol) at -78 °C. The 
resulting solution was added to a stirred solution of methylphosphonothioic 
dichloride 8(11.2 g, 75.2 mmol) in THF (40 ml) at -78 °Cover 1 h. After 7 h 
at -78°C, the mixture was warmed to 25 °C, and diluted with ether (1 O ml) 
and water (1 O ml). The organic layer was separated, washed 
successively with water and brine, dried over anhydrous sodium sulfate, 
and concentrated in vacuo. The residue was subjected to distillation (80 
°C, 0.6 mm) to give 8.43 g (49%) of the silylethyl ester 20. IR (neat) 2940 
(C-H), 2880 (C-H), 620 (P=S) cm-1; 1 H NMR (CDCl3) 0.05 (s, SiCH3, 9H), 
1.10 (t, J = 8.5 Hz, CH2Si, 2H), 2.26 (d, J = 15.4 Hz, PCH3, 3H), 4.30 (m, 
POCH2, 2H) ppm; 13c NMR (CDCl3) -1.6 (SiCH3), 18.8 (d, J = 7.6 Hz, 
POCCH2), 29.8 (d, J = 103.0 Hz, PCH3), 65.7 (d, J = 8.0 Hz, POCH2) ppm; 
31 P NMR (CDCl3) +93.3 ppm; mass spectrum m/e (relative intensity) 203 
([M-28]+, 100), 85 (15), 81 (13). 
Synthesis of (2-Trimethylsilylethyl)oxalyl Chloride. To 
oxalyl chloride (13.6 g, 0.11 mol) was added 2-trimethylsilylethanol (12.5 
g. 0.11 mol), dropwise, with stirring at O °C. The mixture was warmed to 25 
°C, stirred for 15 h, concentrated in vacuo and subjected to distillation (56 
139 
°C, 2.0 mm) , to give 13.6 g (62%) of the mono-ester acid chloride. IA 
(neat) 2930 (C-H) , 1780 (CIC=O), 1740 (OC=O), 1240 (Si-C) cm-1; 1 H 
NMR (CDCl3) 0.05 (s, SiCH3, 9H), 1.12 (t, J = 8.6 Hz, SiCH2, 2H) , 4.43 {t, J 
= 8.4 Hz, OCH2 , 2H) ppm; 13C NMR (CDCl3) - 1.7 (SiCH3), 17.3 (s, 
SiCH2) , 67.9 (s, OCH2), 155.8 (s, COOC), 161 .2 (s, CICO) ppm; mass 
spectrum, m/e (relative intensity) 163 ([M-42]+, 100), 101 (41) . 
Synthesis of (S)-(-)-N-Methyl-N-(1-Phenylethyl)amine 
(21 ) . To a stirred solution of (S)-(-)-N-(1 -Phenyleth-1-yl)amine (14.1 g, 
0.12 mol) and potassium carbonate (78.8 g, 0.57 mol) in THF (100 ml) 
was added a solution ethyl chloroformate (18.9 g, 0.18 mol) in THF (30 
ml), dropwise, with stirring at o °C. After 2 h the reaction was warmed to 
25 °C and stirred at this temperature for 6 h. Water (100 ml) was added 
and the organic layer was separated and washed with water. The 
aqueous extracts were washed ether. The ethereal extracts were dried 
over anhydrous sodium sulfate and concentrated in vacuo to yield 30.0 g 
(99%) of the corresponding carbamate. 1 H NMR (CDCl3) 1.20 (t, J = 7 Hz, 
OCCH3, 3H), 1.48 (d, J = 6.6 Hz, PhCCH3, 3H), 4.08 (q, J = 7.0 Hz, OCH2, 
2H), 4.82 (m, PhCH, 1 H), 5.13 (s, NH, 1 H), 730 (m , Aromatic, 5H) ppm ; 13C 
NMR (CDCl3) 14.1 (CCH3), 21.9 (PhCCH3), 50.0 (PhCH) , 60.1 (OCH2) , 
125.5, 126.5, 127.9 (aromatic CH), 143.7 (aromatic C), 155.6 (NCOO) ppm; 
mass spectrum m/e (relative intensity) 193 (M,+ 47), 178 (100) , 164 (88), 
120 (66), 106 (98), 77 (61 ). 
To a stirred mixture of lithium aluminum hydride (4.7 g, 0.12 mol} in 
THF (100 ml) at O 0 c was added, dropwise, a solution of the carbamate 
(15.2 g, 79.2 mmol) in THF (40 ml) . The solution was warmed to 25 °C 
140 
and stirred at this temperature for 7 h. Ether (200 ml), water (8 ml) and 
0.1 N NaOH (7 ml) were successively added. The mixture was filtered 
through celite and the precipitate was washed with ether (160 ml) and 
chloroform (80 ml). The filtrate and washings were dried over anhydrous 
sodium sulfate and concentrated in vacuo giving a residue which was 
subjected to distillation (25 °c, 0.01 mm) to yield 9.7 g (91 %) of the known 
(Cervinka et al., 1968) phenethyl amine 21. IR (neat) 3280 (N-H), 3100 
(aromatic C-H), 2940 (C-H) cm-1; 1 H NMR (CDCl3) 1.33 (d, J = 6.7 Hz 
PhCCH3, 3H), 1.35 (s, NH, 1 H), 2.29 (s, NCH3, 3H), 3.62 (q, J = 6.6 Hz, 
PhCH, 1 H), 7.25 (m, aromatic H, SH) ppm; 13c NMR (CDCl3) 23.8 
(PhCCH3), 34.4 (NCH3), 60.2 (PhCH), 126.5, 126.8, 128.3 (aromatic CH), 
145.3 (aromatic C) ppm; mass spectrum m/e (relative intensity) 134 
([M+ 1 ]+, 20), 120 (100), 105 (22), 77 (30). 
(Sp,Sc)- and (Rp,Sc)-N,P-Dimethyl-N-(1-Phenylethyl)-O-
(2-(Trimethylsilyl)ethyl Phosphonamidothioate (22a and 22b). 
To a stirred solution of (S)-N-methyl-N-(1-phenylethyl)amine 21 (2.20 g, 
16.3 mmol) in THF (100 ml) was added, dropwise, n-butyllithium (1 .2 M, 
11.3 ml, 13.6 mmol) at -78 °C. To this solution was added, dropwise, a 
solution of the methylphosphonochloridate 20 (3.13 g, 13.6 mmol) in THF 
(2 ml). The reaction mixture was stirred for 5 h. after which time ether (20 
ml) and water (20 ml) were added. The organic layer was separated, 
washed successively with water and brine, dried over anhydrous sodium 
sulfate and concentrated in vacuo. The resulting residue was subjected to 
flash silica chromatography (4% ether in cyclohexane) affording 3.86 g 
(86%) of a mixture of the thiophosphonamidate diastereomers 22a and 
22b . The diastereomeric mixture was then subjected to HPlC 
1 4 1 
chromatography (silica gel, 4% ether in cyclohexane) to give 1.53 g (34%) 
of the first eluting diastereomer, 22a, and 1.34 g (30%) of the second 
eluting diastereomer, 22b. 
22a: IR (neat) 2920 (C-H), 1290 (P-C), 1050 (P-O-C), 970 (P-O-C), 
620 (P=S) cm-1; 1 H NMR (CDCl3) 0.02 (s, SiCH3, 9H), 1.00 (m, CH2Si, 
2H}, 1 .48 (d, J = 7 Hz PhCH3, 3H), 1.73 (d, J = 14.6 Hz, PCH3, 3H), 2.36 
(d, J = 10.0 Hz, NCH3, 3H), 3.80 (m, POCHA, 1 H), 4.11 (m, POCHB, 1 H), 
5.58 (m, PhCH, 1 H), 7.25 (m, aromatic H, 5H) ppm; 13c NMR (CDCl3) -1.4 
(SiCH3), 16.8 (PhCCH3), 19.3 (d, J = 7.5 Hz, SiCH2), 20.3 (d, J = 109.0 
Hz, PCH3), 26.9 (d, J = 15.3 Hz, PNCH3), 53.2 (d, J = 6.1 Hz, PhC), 61.7 
(d, J = 4.9 Hz, POCH2), 127.0, 127.2, 128.2 (aromatic CH),141.4 (d, J = 5.3 
Hz, aromatic C) ppm; 31 P NMR (CDCl3) +85.2 ppm; mass spectrum m/e 
(relative intensity) 330 ([M+ 1 ]+, 100) 113 (19), 85 (53), 81 (64); HRMS m/e 
330.1480 (M+ 1) (C15H28NOPSSi requires 330.1477). 
22b: IR (neat) 2920 (C-H), 1290 (P-C), 1050 (P-O-C), 970 (P-O-C), 
620 (P=S) cm- 1; 1 H NMR (CDCl3) -0.03 (s, SiCH3, 9H), 0.87 (m, SiCHA, 
1 H), 1.00 (m, SiCHB, 1 H), 1.44 (d, J = 7.0 Hz, PhCCH3, 3H), 1.77 (d, J = 
14.4 Hz, PCH3, 3H), 2.37 (d, J = 10.0 Hz, PNCH3, 3H), 3.68 (m, POCHA, 
1 H), 4.09 (m, POCHB, 1 H), 5.53 (m, PhCH, 1 H), 7.21 (aromatic H, 1 H), 
7.30 (aromatic H, 2H) 7.38 (aromatic H, 2H) ppm; 13c NMR (CDCl3) -1.6 
(SiCH3), 16.3 (d, J=2.1 Hz, PhCCH3), 18.9 (d, J= 7.5 Hz, SiCH3), 21.2 (d, 
J=107.5 Hz, PCH3), 26.7 (d, J=2.8 Hz, NCH3), 53.3 (d, J=6.4 Hz, PhCH), 
61.6 (d, J=6.9 Hz, POCH2), 126.9, 127,4, 128.1 (aromatic), 141.5 (d, J=4.6 
Hz, aromatic), 186.4 (d, J = 5.3 Hz, PCCO) ppm; 31 P NMR (CDCl3) + 84.5 
ppm; mass spectrum m/e (relative intensity) 330 ([M+ 1] +, 100), 302 (73), 
142 
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intervals of crysta l X-ray exposure. The standard intensity change range 
and average was -1.9 to 0.6% and -0.5%. Eighteen hundred and fi fty total 
data were measured (includes space group absences) ; 1731 unique data; 
1498 I > 3a(I). All crystallographic calculations were performed with the 
TEXSAN program system 11 8 on a DEC MicroVax II computer. The 
structure was solved with the MITH RIL 119 link incorporated in TEXSAN. 
Full matrix least squares refinement: r-(a-2(F0 )(Fo-Fc)2) minimized ; 
anisotropic temperature factors for C, 0 , N, P and S and isotropic terms for 
H ; reflections with k3a(I) excluded from refinement; final R, Rwtd, 
goodness-of-fit and f../a of 0.036, 0.042, 1.62 and 0.06. Maximum and 
minimum values in final f..p map of 0.18 and -0.17 eA-3. Atomic scattering 
factors were obtained from the International Tables for X-ray 
Crystallography (1974). A Table of atomic coordinates and temperature 
factors , bond lengths and angles and structure factors are given as 
supplementary material. The PLOTMD program120 was used to display the 
ORTEP (Johnson, C. K. (1965) ORTEP, Report ORNL-3794, Oakridge 
National Laboratory, TN, USA) drawing on a VaxStation II monitor, to label 
the drawings and to prepare a print for a Hewlett-Packard Laser-Jet II 
printer. The structure is displayed in Figure 5. 
(Sp,Sc)- and (Rp,Sc)-3-[[Methyl(1-Phenylethyl)amino][2-
(trimethylsilyl)ethoxy]phosphinothioyl]-2-0xo-2-
(Trimethylsilyl)ethyl Propanoate (23a and 23b). To each 
separate, stirred solution of the methylthiophosphonamidate 
diastereoisomer 22a or 22b (0.51 g, 156 mmol) in THF (1 ml) was added, 
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afforded 0 .21 g (56%) of each of the pure deprotected 
thiophosphonamidate diastereomers, 24a and 24b. 
24a: 1 H NMR (OMSO-d6) 1.36 (d, J = 7.0 Hz, PhCCH3, 3H), 2-
30 
(d, J = 10.4 Hz, PNCH3, 3H), 3.12 (dd, J = 10.6 Hz, J = 15.5 Hz, PCHA, 
1 H), 3.26 (dd, J = 10.6 Hz, J = 15.5 Hz, PCHs, 1 H), 5.25 (m, PhCH, 1 H), 
7.30 (m, aromatic CH, SH) ppm; 31 P NMR (OMSO-d6) + 57.2 ppm. 
24b: 31 P NMR (OMSO-d6) +57.0 ppm. 
Preparation of the (Ap )· and (Sp) · 
[P= 180JThiophosphonopyruvates (31 a and 31 b) by Hydrolysis 
of 24a and 24b in [1 Bo] H20. Compounds 24a and 24b (0.134 9, 
0.24 mmol) were mixed with [1 Bo] H2O (98%) (1250 µl, 62.5 mmol) and 
HCI (12 M, 45 µl, 0.54 mmol) then immediately quenched with 1.3 ml of 
020 containing K2HP04 (80 mM), Mgc12 (5 mM), dithiothreitol (0.8 mM) 
and sufficient KOH to bring the pH of the resulting solutions 8.0. This 
procedure yielded from 24a (Rp)-f P= 18Q]thiophosphonopyruvate (31a) 
(0.17 mmol), and [P= 1802Jphosphonopyruvate (0.07 mmol) and from 24b 
(Sp )-[P= 1 80Jthiophosphonopyruvate 31 b (0.17 mmol) and [P= 
1802J 
phosphonopyruvate (0.07 mmol). 31 p NMR (020) + 44.8 ppm (t, J = 18.2 
Hz) for 31 a and 31 b and + 10.6 ppm (t, J=20.4 Hz) for the 
phosphonopyruvate. These samples were used without purification. 
Selective Op-Detrimethylsilylethylation of 23a. To a stirred 
mixture of cesium fluoride (0. 11 g, 657 µmol) and 18-crown-6 (0. 17 g, 657 
µmol) in dry acetonitrile (5 ml) was added a solution of 
thiophosphonamidate 23a (0.33 g, 657 µmol) in dry acetonitrile (3 ml). 
148 
The reaction mixture was stir
red at 25 °C for 3 h and th
en centrifuged 
(14,000 g x 2 min). The supernatant wa
s concentrated in vacuo to yield
 a 
residue containing the desir
ed mono-deblocked thiophos
phonamidate 
(42a) (61%) (31p NMR (CDC
l3} +53.7 and +62.4 ppm for 
the keto and 
enol forms), the enol form of
 unreacted 23a (25%) (
31 P NMR (CDCl3) 
+81 .1 ppm) and the oc-detrim
ethylsilylethylated derivative 
(43a) (12%) 
(31 P NMR(CDCl3) +76.3 ppm)
. 
[ P= 18Q]Thiophosphonopy
ruvates (31 a and 31 b) 
by 
Hydrolysis of Op-Desilyle
thyl-23a (42a) in [
180]H20. To the 
mixture containing Op-desilyle
thyl 12a (400 µmol) was adde
d [1801 H2o 
(98%) (69 µl) and p-toluenes
ulfonic acid (0.122 g, 640 µmm
ol). After 20 
min at 25 °C the mixture was d
iluted with 100 ml of Hepes bu
ffer (100 mM) 
and the pH of the resulting so
lution was adjusted to 8 with 
KOH solution. 
31 P NMR (D2O) analysis the
 product mixture revealed tha
t it contained 
10% of the desired [P= 18Q]t
hiophosphonopyruvate (+44.
8 ppm) along 
with the Op-trimethylsilylethy
l ester of [P= 18Q]thiophosph
onopyruvate 
(35%, +64 .0 ppm), thio
phosphate (34%, +35 .6 
ppm) and 
phosphonopyruvate (12%, + 10








To each stirred solution of 22a 
and 22b (0.20 g, 0.61 mmol) in 
THF (1 ml) 
was added , dropwise, n-bu
tyllithium (1 .2 M 0.56 ml o 67 
I) • 
• , • mmo in 
hexanes at -78 °C. After 30 
min, cuprous iodide (0.13 g, 0
.67 mmol) in 
149 
THF (5 ml) was added. The mixtures
 were warmed to -30 °Cover 1 h, and 
stirred at this temperature for 2 h. 
Solutions of the known 
11 2-propyl 
oxalyl chloride (0.12 g, 0.8 mmol) in 
ether (2 ml) were added dropwise to 
the mixtures, and each was stirred at 
-30 °c for 7 h and then warmed to 25 
°C. Water (7 ml) was added and 
the resulting solutions were filtered 
through celite. The precipitates were
 washed with methylene chloride (20 
ml) and the filtrates were refiltered. 
The methylene chloride layers were 
separated, dried over anhydrous s
odium sulfate and concentrated in 
vacuo . The resulting residues were su
bjected to chromatography on 
Florisil (30% ether in cyclohexane
) to yield (40%) in pure form the 
individual thiophosphonamidate est
ers 45a and 45b. 
45a: IR (neat) 3020 (aromatic C-H), 
2940 (C-H), 1750 (C=O), 1720 
(O==C-OR) cm-1; 1 H NMR (CDCl3) -0.
01 (s, Si(CH3)3, 9H), 1.00 (m, SiCH2, 
2H), 1.33 (d, J == 6.3 Hz, COC(CH3)2
, 6H), 1.49 (d, J = 7.0 Hz, PhCCH3, 
3H), 2.42 (d, J == 10.5 Hz, PNCH3, 3H)
, 3.59 (dd, J == 20.6, 12.0 Hz, PCH2, 
1 H), 3. 76 (dd, J == 20.6, 12.0 Hz, PCH2
, 1 H), 3.84 (m, POCHA, 1 H), 4.10 (m, 
POCHs, 1 H), 5.12 (m, COCH, 1 H), 5
.48 (m, PhCH, 1 H), 7.30 (m, aromatic 
H, SH) ppm; 13c NMR (CDCl3) - 1.6 (S
iCH3), 17.0 (d, J=2.5Hz, PhCCH3), 
19.0 (d, J == 6.5 Hz, SiCH2), 21.4 (d, 
J=2.8 Hz, COCCH3), 27.2 (d, J = 2.8 
Hz, PNCH3), 44.9 (d, J == 88.2 Hz, PCH
2), 53.6 (d, J = 6.5 Hz, PhCH), 62.8 
(d, J = 7.1 Hz, POCH), 70.9 (COCH), 
127.3, 128.3 (aromatic CH), 140.6 (d, 
J = 4.9 Hz, aromatic C), 160.3 (CO2)
, 186.9 (d, J = 4.4 Hz, PCCO) ppm; 
31 
P NMR (CDCl3) +76.4 ppm; mass spe
ctrum; HAMS m/e 444.1787 (M+ 1) 
(C20H34NO4PSSi requires 444.1794
). 
45b: IR (neat) 3050 (aromatic C-H), 
2950 (CH), 1750 (C=O), 1720 
(O=C-OR) cm-
1; 1 H NMR (CDCl3) 0.08 (s, Si(CH3)3, 
9H), 0.88 (m, CH2
Si, 
150 
2H), 1.31 (d, J = 6.3, OC(CH3)2, 6H), 1.42 (d, J = 7.1 Hz, PhCHCH3, 3H), 
2.37 (d, J = 10.1 Hz NCH3, 3H), 3.57 (dd, J = 19.4, 12.0 Hz, PCH2, 1 H), 
3.65 (m, POCH2, 1 H), 3.91 (dd, J = 19.9, 12.0 Hz, PCH2, 1 H), 4.05 (m, 
POCH2, 1 H), 5.64 (m, PhCH, 1 H), 7.28 (m, aromatic CH, SH) ppm. 13C 
NMR (CDCl3) -1.62 (s, SiCH3), 16.1 (d, J = 2.1, PhCH3), 18.9 (d, J = 
6.4 Hz, CH2Si), 21.5 (s, OCH(CH3)2), 26.8 (s, NCH3), 45.1 (d, J = 88.1 Hz, 
PCH2), 53.6 (d, J = 6.9 Hz, PhCH), 62.6 (d, J = 7.4 Hz, POCH2), 71.1 (s, 
OC.QH3), 127.2, 127.6, 128.2 (aromatic CH), 141.1 (d, J = 4.5 Hz, aromatic 
C), 160.4 (s, CO2), 187.2 (d, J = 4.6 Hz, PCCO) ppm; 31 P NMR (CDCl3) 
+ 75.8 ppm; mass spectrum m/e (relative intensity) 502 ([M+ 1 J+, 11 ), 342 
(15), 286 (47), 252 (65), 134 (99), 120 (100); HAMS m/e 444.1777 (M+1) 
(C20H34NO4PSSi requires 444.1794). 
(Sp, Sc)- and (Rp,Sc)-3-[[Methyl(1-
Phenylethyl)am i no Jphosphi nothioyl]-2-0xo-(2-
Propyl)propanoate (46a and 46b). To each stirred solution of 45a 
and 45b (90 mg, 0.20 mmol) in dry acetonitrile (2ml) were added cesium 
fluoride (32 mg, 0.21 mmol) and 18-crown-6 (54 mg, 0.20 mmol) in dry 
acetonitrile (3 ml) under a nitrogen atmospheres. The reaction mixtures 
were stirred for 30 h at 25 °C and concentrated in vacuo to afford the 
crude thiophosphonamidate esters 46a and 46b (85%), respectively . 
46a ( ca. 1 :1 mixture of enol and keto tautomers): 1 H NMR (CDCl3) 
1.18 (d, J = 1. 7 Hz, CCH3, 3H), 1.20 (d, J = 1. 7 Hz, CCH3, 3H), 1.26 (d, J = 
2.4 Hz, CCH3, 3H), 1.27 (d, J = 2.4 Hz, CCH3, 3H), 1.43 (d, J = 7.0 Hz, 
PhCCH3, 6H, both tautomers), 2.39 (d, J=10. 7 Hz, NCH3, 3H), 2.46 (d, 
J=10.9 Hz, NCH3, 3H), 3.48 (dd, J=10.4, 17. 7 Hz, PCHA, keto form, 1 H), 
1 5 1 
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hich HCI (
22 µI, 12 M
, 90 µmo/) 
had been 
added Th
e . t 
. bated
 at 4° c tor 40








with 250 µL of HEPES
 solution (200 mM) and the pH o
f the resulting 
solutions was adjusted to 8_ 31 P-
NMA analysis of the product mixtu
res 
revealed that the desired [S, 1 Bo,
 160-P]thiophosphonopyruvates 31
 a 
and 31 b were formed in an ca. 10% y
ield. These compounds were used 
in subsequent experiments without 
purification. 
Enzymatic Conversion of t
he (Rp)- and (Sp)-[P= 
1 8 O,]Thiophosphonopyruvates 
(31 a and 31 b) to the 
[P= 1 BoJThiophosphenolpyruvat
es (29a and 29b). The (Sp)- and
 
(Ap)-[P= 1 Bo]thiophosphonopyruva
tes (31a and 31 b) (170 µmol), derive
d 
from the H2 1 Bo hydrolysis 
of either 24a and 24b(170 µmol) or 
46a and 
46b (17 µmol), were separately r
eacted at 25°C with 1.8 units of PE
P 
phosphomutase in a 5 ml solution
 of 5 mM MgCl2, 0.8 mM dithiothrei
tol 
and 50 mM K+HEPES (pH 8.
0) in 50% D2O. The formation
 of 
thiophosphoenolpyruvates 29a and
/or 29b was complete within 7 h (31 p
 
NMA). In the case of the 
catalyzed reaction of the (Sp
) -
[P= 1 8O]thiophosphonopyruvate ge
nerated from the H2
1 Bo hydrolysis of 
Op-desilylethyl-23a (42a), MgCl2 (t
o a final concentration of 2.5 mM) a
nd 
PEP phosphomutase (0.08U) w
ere added directly to the buffer
ed 
hydrolysate. The 31 P NMA (D2O, 
pH 8) analysis of the resulting react
ion 
mixtures revealed tha











29a and/or 29b to [y-180. 
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PJATPS. Samp\es oi lP=18O1thiophosphoenolpyruvate (17 - 170 µmo\) 
generated by reaction oi 3'1a and 3'1b with PEP phosphomutase were 
converted directly to l'y-18O-P1ATP-yS by incubation with ADP ( 15 - 25 
m M ), MgC\2 (2.5 mM) and pyruvate kinase (250 - 2000 units) in 1 ml 
K +HEPES (50 mM, pH 8.0) at 25 °C ior 12 h. The l'y18Q-P1ATP-yS was 
puriiied irom the reaction mixture by chromatography on a (2 x 40 cm) 
oEAE Sephadex A-25 column with 1.5 l oi a \inear gradient oi TEAB, 0.15 
M to o.70 M at pH 8.1 serving as the eluant . Fractions containing l-y-18o-
P1ATP-yS were pooled and concentrated in vacuo . The residue was 
dissolved in 10 ml oi water and concentrated. This process was repeated 
-tour times in order to remove residual TEAB. The yield oi the l'Y-
18O11ATP-yS was estimated by 31 P-NMR to be~- 70%. 
The l'Y_ 18Q-P1ATP"(S ( 15 - 110 µmo\) was converted to l\)-18Q-P1ADP\)S by 
reaction with myokinase (500 units) in a 5 ml solution containing 1 0 mM 
MgC\2, 0 .1 mM dithiothreitol , 15-120 mM AMP and 50 mM Tris-HCI (pH 
8 .0) . The progress oi the reaction was monitored by 31 P NMR. Atter 1 h 
at 25 °c the reaction was ca. 80% complete. The lr>-18Q-P1ADP\)S was 
puriiied irom the reaction mixture by chromatography on a DEAE 
Sephadex A-25 column (1.5 x 35 cm) equilibrated with 0.10 M TEAB (pH 
8.1 ) . The column was eluted with a 1.5 l linear gradient oi TEAB (0 .10 M 
to 0.4 M) . Fractions containing lr>-18Q-P1ADP\)S were pooled and 
concentrated in vacuo. Residual TEAB was removed by dissolving the 
residue in 1 0 ml oi water iollowed by concentration in vacuo. The yield oi 
lr>-18Q-P1ADP\)S was estimated by 31 P NMR analysis to be ca. 60%. The 
l\)-18Q-P1ADP\)S (7-70 µmo\) was converted to (Sp)-tr,-18Q-P1ATP\)S by 
incubation in a 5 ml (50% D2O, 25 °C) solution containing MgC\2 (4 mM) , 
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KCL (380 mM), dithiothreito\ (0.8 mM), 'TR\S-\-\C\ (40 m
M, p\-\ 8) , PEP (10 -
70 µ.mo\) and 250 units oi pyruvate kinase . 1he reac
tion, monitored by 
31 P NMR, and was iound to be comp\ete in 12 h. ,he r
eaction mixture 
was concentrated in vacuo and the residue obtained
 was disso\ved in 0.5 
rnL oi D20 containing ED1A (0.2 M) and 1R\S-\-\C\ 
(1 M, p\-\ 8.0) and 
sub\ected to 31 p NMR ana\ysis. ,he spectrum oi 
this substance was 
obtained on a Bruker AM 400 instrument at 160 M\-\z. w
ith a deuterium iie\d 
\oc\<..~ spectra\ width 11363 \-\z.~ acquisition time 1.44 
s·, pu\se width 8 µ.s·, 
re\axation de\ay 5s~ number oi transients, 3000. 
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Rapid Quench Experiments. All solutions were buffered with 
K+HEPES (50 mM, pH 7.5). A buffered solution (43 µL) contai
ning PEP 
mutse , MgCl2 was mixed via the rapid quench instrument with a
 buffered 
solution (43µL) containing [3HJP-pyr to give final concentrati
ons after 
mixing of PEP mutase (20-25 µM, Mol. Wt. 78,000), MgCl2 (5 mM
), [3HJP-
pyr (5 µM, specific activity, 40 Ci/mol) After a specified time the
 solution 
was quenched with 164 µL of K+HEPES (20 mM, pH 1.6). T
wo µL of 
NaCNBH3 (1 M solution in THF,2 µL, 2 µmo/) were added to the re
action 
mixture. After 15 min the pH of the reaction mixture was neutra
lized with 
KOH (1 M, 1 o µL). Fifty µL of CC/4 were added to the resulting solution and 
it was vortexed to prcipitate the protein. After centrifugation
 the total 
supernatant was analyzed for radioactive PEP, P-Lac, and l
actate by 
separation using HPLC and quantitation using liquid scintillation 
counting. 
Control studies to test the efficient of NaCNBH3 Reduction 
of P-
pyr and pyruvate Phosphonopyruvate (75 mM) and phosphoenolpyruvate
 (75 
mM) were reacted separately with 75 mM NaCNBH3 at 25°C for
 15 min at pH 2. 
After adjusting the pH of the solutions to 8 the reaction 
products were 
concentrated in vacuo and dissolved in D20. 
Synthesis and Analysis of [3HJP-pyr The phosphonopyruvate 
was labeled with tritium by exchange of the C-2 protons in 11
 o Ci/mol 
[3HJwater at 25°C at pH 9 (the pH of a solution of Li3P-pyr). Afte
r 24 h the 
[3HJP-pyr was precipitated with ethanol and dried in vacuo, thus 
producing 
[3HJP-pyr with a specific activity of 40 Ci/mol. A 1 O µM solution of [
3HJP-pyr 
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in 50 mM K+HE
PES (pH 7.5) w
as prepared imm
ediately before 




ivity of the [
3H]P-pyr was det





 P-pyr (340 nm
, pyruvate 
kinase/ ADP co
upling to PEP m
utase catalyzed




 to pyruvate form
ation) and tritium
 counting 




Bond angles (0) and estill''lted 
standard deviations (in 
parentheses) for compound iO 
·atom atom atom angle 
atom atom atom ung le 
CB s p 
99.3 (1) 
C3 C4 N2 
118.8(4) 
01 p 
Nl 111.6 (2) · cs C4 N2 
117.8 (4) 
01 p 
ClB 114.9(3) C4 cs CG 
117 . 7(4) 
01 p s 
114 . 1(1) cs CG Cl 
121 ; 1(4) 
Nl p 
Cl8 109.4(3) 0 2 · C7 Cl 
120 . 1(4) 
Nl p s 107.9(1) 02 C7 CB 
, 120 .. 9(4) 
ClB p s 98 . 1 (2) Cl C7 CB 
118.9(4) 
C9 Nl cu 117 . 2(3) C7 CB s 
109, 9 (3) 
C9 Nl p 
121. 5 (3) Nl Cll C12 
110 . 2(3) 
Cll Nl p 
' 120.9(3) Nl Cll ClO 
110 . 8(4) 
04 N2 03 124.0(S) 
c12 C).1 ClO 
114 , 4(4) 
04 N2 .C4 118.1(4) 
Cl3 C12 Cl7 
117 . 6(5) 
03 N2 C4 117 . 9(5) 
Cl3 Cl2 Cll 
122.9(4) 
CG Cl C2 118.5(4) 
Cl? Cl2 Cll 
119 . 4 (4) 
CG Cl C7 118.7(4) 
Cl4 C13 Cl2 
120 . 8(5) 
C2 Cl C7 122.8(4) 
ClS Cl4 Cl3 
120. 8 (5). 
CJ C2 Cl 121.1(4) C14 C15 C16 
119 . 4(5) 
C4 .CJ C2 118.1(4) Cl? C16 ClS 
119 . 9(5) 
CJ C4 cs 123,4 (4) Cl6 Cl? c12 
121:5(5) 
158 
Table. Bonds distances !Al and estimated standard deviations (in parentheses) for compound ~O 
atom atom distance atom atom distance 
s CB 1.804(4) C2 C3 1.373(6) 
s p 2.089(2) C3 C4 1.366(6) 
p 01 1.472(3) C4 cs 1.377(6) 
p Nl 1. 636 (3) cs CG 1.377(6) 
i' ClB 1.794(5) C7 . CB 1.499(6) 
02 C7 1.202 (5) Cl0 Cll 1. 525 (7) 
03 N2 1.205(5) Cll C12 1.523(6) 
04 N2 1.197(6) C12 C13 1.380(6) 
Nl C9 1.463(6) Cl2 C17 1.394(6) 
Nl Cll 1.490(5) C13 C14 1.378(7) 
N2 C4 1.480(6) Cl4 ClS 1.364(7) 
Cl C6 1.392(5) ClS C16 1.383(7) 
Cl C2 1.397(5) C16 C17 1.365 (7) 
Cl C7 1.489(6) 
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Table. Fractional coordinates, equivalent isotropic 
temperature factors (A2 ) and estimated standard deviations 
(in parentheses) for compound ~O 
atom X y z B 
s 0.4746(2) 0.1350(1) 0.36276(3) 5. 35 (5) 
p 0.5540(1) 0.0271(1) 0.31219(3) 4. 04 ( 4) 
01 0.4148(4) -0.1002(4) 0. 29747 (8) 5. 4 ( l) 
02 0.428(1) 0.1336(4) 0.43958(9) 10. 0 (3) 
03 0.441(1) -0.5039(6) 0.57121(9) 11. 3 (3) 
04 0 . 438(1) -0.7007(5) 0.5301(1) 12. 5 (4) 
Nl 0. 7 682 ( 4) -0.0592(4) 0.31688(9) 4. l ( 1) 
N2 0.441(1) -0.5507(7) 0.5396(1) 7. 6 (3) 
Cl 0.4473(7) -0.1591(5) 0. 4578 (1) 4 ·. 6 (2) 
C2 0.4483(8) -0.3362(5) 0 . 4482(1) 4. 9 (2) 
C3 0.4469(8) -0.4645(6) 0.4747 (1) 5 .1 (2) 
C4 0.4446(7) -0.4141(6) 0.5107(1) 5. 1 (2) 
cs 0.4448(8) -0.2418(7) 0.5218(1) 5 .1 (2) 
C6 0.4446(8) -0.1148(6) 0.4949(1) 5 . 0 (2) 
C7 0 . 4451(8) -0.0161(6) 0.4300(1) 5. 5 (2) 
cs 0.4715(9) -0.0618(6) 0.3902(1) 4. 8 (2) 
C9 0.9292(8) 0.0409(7) 0.3322(2) 4 . 9 (2) 
ClO 0.932(1) -0.2231(8) 0.2669(1) 5. 8 (3) 
Cll 0.8120(6) -0.2363(6) 0.3020(1) 4. 0 (2) 
Cl2 0.9004(6) -0.3510(6) 0.3318(1) 4. 1 (2) 
Cl3 1.0963(7) -0.3782(7) 0.3350(1) 4. 8 (2) 
Cl4 1.1695(8) -0.4820(7) 0.3626(2) 6.1 (3) 
Cl5 1. 0504 (9) -0.5576(6) 0. 3879 (1) 5.8(3) 
Cl6 0.8537(9) -0.5320(7) 0.3852(1) 5. 7 (3) 
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C17 0.7808(7) -0.4309(6) 0.3576(1) 4. 8 (2) 
C18 0.572(1) 0.2270(9) 0.2865(2) 6 . 3 (3) 
H2 0.439(6) -0.368(5) -0.421(1) 6 ( 1) 
H3 0.455(7) -0.589(6) 0.468(1) 6 ( 1) 
HS 0.441(6) -0.215(4) 0.547(1) 3. 6 (8) 
H6 0.458(7) 0.002(5) 0.500(1) 5 ( 1) 
HBA 0.373 (6) -0.125(6) 0.383(1) 5 ( 1) 
H8B 0.605(7) -0.130(7) 0.386(1) 1 C 1) 
H9A 0.961(8) 0.003 (7) 0.357(2) 9 (2) 
H9B 1.02 (1) I), 01 ( 1) 0.319(2) 13(3) 
H9C 0. 89 (1) 0.157(8) 0.331(1) 9 ( 2) 
!HOA 0 . 8613(7) -0.161(7) 0.250(1) 7 ( 1) 
HlOB 1.054(9) -0.173(7) 0 .273 (1) 8 (2) 
HlOC 0.963(8) -0.349(7) 0.258 (1) 8 (1) 
Hll 0.688(6) -0.286(5) 0.297(1) 3. 8 ( 9) 
!113 1.170(6) -0.326(6) 0.318(1) 5 ( 1) 
!114 1,295(7) -0.501(7) 0.365 (1) 7 ( 1) 
H15 1.101(7) -0.624(6) 0.406 (1) 6 ( 1) 
Hl6 0.778(7) -0.581(7) 0.402(1) 6 ( 1) 
Hl7 0.659(6) -0.414(6) 0.354(1) 5 ( 1) 
!!18A 0. 4 6 (1) 0.279(7) 0.289 (1) 8 (2) 
1118B 0. 68 ( 1 l 0 .30 (1) 0.294 (2) 10 (2) 
HlBC 0.588(7) 0.192(6) 0.261(1) 7 (1) 
1 6 1 
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